UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON D.C. 20549
FORM 10-Q
x QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
For the quarterly period ended March 31, 2005
Commission file number 1-71
New Jersey | 13-0511250 | |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
180 East Broad Street, Columbus, Ohio 43215
(Address of principal executive offices)
(614) 225-4000
(Registrants telephone number, including area code)
Not Applicable
(Former name, former address and former fiscal year, if changed since last report)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes ¨ No x
Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x
Number of shares of common stock, $0.01 par value, outstanding as of the close of business on May 10, 2005: 96,905,936
INDEX
2
Item 1. Borden Chemical, Inc. Condensed Consolidated Financial Statements
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE (LOSS) INCOME (Unaudited)
BORDEN CHEMICAL, INC.
(In thousands, except per share data) |
Three Months ended March 31, | ||||||
2005 |
2004 | ||||||
Net sales |
$ | 485,166 | $ | 385,434 | |||
Cost of goods sold |
395,309 | 310,249 | |||||
Gross margin |
89,857 | 75,185 | |||||
Distribution expense |
21,345 | 17,328 | |||||
Marketing expense |
11,959 | 11,403 | |||||
General & administrative expense |
23,745 | 22,874 | |||||
Transaction related costs (see Note 1) |
1,500 | | |||||
Business realignment and impairments (income) expense |
(382 | ) | 1,494 | ||||
Other operating (income) expense |
(279 | ) | 1,284 | ||||
Operating income |
31,969 | 20,802 | |||||
Interest expense |
21,785 | 11,890 | |||||
Other non-operating expense |
9,113 | 61 | |||||
Income before income tax |
1,071 | 8,851 | |||||
Income tax expense |
5,333 | 3,937 | |||||
Net (loss) income |
$ | (4,262 | ) | $ | 4,914 | ||
Comprehensive (loss) income |
$ | (6,327 | ) | $ | 5,638 | ||
Basic and Diluted Per Share Data |
|||||||
Net (loss) income - basic and diluted |
$ | (0.04 | ) | $ | 0.02 | ||
Average number of common shares outstanding during the period basic |
96,906 | 199,308 | |||||
Average number of common shares outstanding during the period diluted |
96,906 | 200,449 |
See Notes to Condensed Consolidated Financial Statements
3
CONDENSED CONSOLIDATED BALANCE SHEETS
BORDEN CHEMICAL, INC. (Unaudited)
(In thousands)
ASSETS |
March 31, 2005 |
December 31, 2004 |
||||||
Current Assets |
||||||||
Cash and equivalents |
$ | 124,308 | $ | 122,111 | ||||
Accounts receivable (less allowance for doubtful accounts of $9,754 in 2005 and $10,197 in 2004) |
217,618 | 226,235 | ||||||
Inventories: |
||||||||
Finished and in-process goods |
54,008 | 55,656 | ||||||
Raw materials and supplies |
51,241 | 54,768 | ||||||
Other current assets |
16,288 | 22,991 | ||||||
463,463 | 481,761 | |||||||
Other Assets |
62,327 | 53,314 | ||||||
Property and Equipment |
||||||||
Land |
33,174 | 32,945 | ||||||
Buildings |
103,493 | 103,504 | ||||||
Machinery and equipment |
734,833 | 733,285 | ||||||
871,500 | 869,734 | |||||||
Less accumulated depreciation |
(430,736 | ) | (421,728 | ) | ||||
440,764 | 448,006 | |||||||
Goodwill |
50,455 | 50,682 | ||||||
Other Intangible Assets |
9,897 | 10,351 | ||||||
Total Assets |
$ | 1,026,906 | $ | 1,044,114 | ||||
See Notes to Condensed Consolidated Financial Statements
4
CONDENSED CONSOLIDATED BALANCE SHEETS
BORDEN CHEMICAL, INC. (Unaudited)
(In thousands, except share data)
LIABILITIES AND SHAREHOLDERS DEFICIT |
March 31, 2005 |
December 31, 2004 |
||||||
Current Liabilities |
||||||||
Accounts and drafts payable |
$ | 208,316 | $ | 222,173 | ||||
Debt payable within one year |
8,181 | 11,588 | ||||||
Income taxes payable |
33,616 | 31,556 | ||||||
Interest payable |
15,956 | 26,022 | ||||||
Other current liabilities |
92,426 | 74,417 | ||||||
358,495 | 365,756 | |||||||
Other Liabilities |
||||||||
Long-term debt |
955,157 | 955,816 | ||||||
Non-pension post-employment benefit obligations |
110,824 | 114,502 | ||||||
Other long-term liabilities |
157,341 | 156,865 | ||||||
1,223,322 | 1,227,183 | |||||||
Commitments and Contingencies (See Note 8) |
||||||||
Shareholders Deficit |
||||||||
Common stock - $0.01 par value: authorized 300,000,000 shares, Issued 200,167,297, treasury 103,261,361, outstanding 96,905,936 shares in 2005 and 2004 |
969 | 969 | ||||||
Paid-in capital |
1,286,743 | 1,274,358 | ||||||
Treasury stock |
(295,881 | ) | (295,881 | ) | ||||
Receivable from parent |
(572,816 | ) | (560,672 | ) | ||||
Accumulated other comprehensive loss |
(109,558 | ) | (107,493 | ) | ||||
Accumulated deficit |
(864,368 | ) | (860,106 | ) | ||||
(554,911 | ) | (548,825 | ) | |||||
Total Liabilities and Shareholders Deficit |
$ | 1,026,906 | $ | 1,044,114 | ||||
See Notes to Condensed Consolidated Financial Statements
5
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
BORDEN CHEMICAL, INC.
(In thousands) |
Three months ended March 31, |
|||||||
2005 |
2004 |
|||||||
Cash Flows from (used in) Operating Activities |
||||||||
Net (loss) income |
$ | (4,262 | ) | $ | 4,914 | |||
Adjustments to reconcile net (loss) income to net cash from (used in) operating activities: |
||||||||
Depreciation and amortization |
12,360 | 11,943 | ||||||
Unrealized loss (gain) on derivative instruments |
9,809 | (145 | ) | |||||
Business realignment and impairments (income) expense |
(382 | ) | 1,494 | |||||
Gain on sale of venture interest |
(1,614 | ) | | |||||
Deferred tax expense (benefit) |
908 | (1,362 | ) | |||||
Other non-cash adjustments |
(10 | ) | 981 | |||||
Net change in assets and liabilities: |
||||||||
Accounts receivable |
8,323 | (3,613 | ) | |||||
Inventories |
4,930 | 2,238 | ||||||
Accounts and drafts payable |
(13,526 | ) | 15,986 | |||||
Income taxes |
2,126 | (1,025 | ) | |||||
Other assets |
6,609 | (8,034 | ) | |||||
Other liabilities |
(13,099 | ) | (17,546 | ) | ||||
12,172 | 5,831 | |||||||
Cash Flows (used in) from Investing Activities |
||||||||
Capital expenditures |
(6,481 | ) | (7,471 | ) | ||||
Deferred acquisition costs (see Note 1) |
(9,128 | ) | | |||||
Proceeds from the sale of venture interest |
2,507 | | ||||||
Proceeds from the sale of assets |
| 8,105 | ||||||
(13,102 | ) | 634 | ||||||
Cash Flows (used in) from Financing Activities |
||||||||
Net short-term debt repayments |
(3,407 | ) | (3,026 | ) | ||||
Borrowings of long-term debt |
| 3,028 | ||||||
Repayments of long-term debt |
(663 | ) | | |||||
Purchase price adjustment payable to parent (see Note 5) |
7,500 | |||||||
Affiliated loan repayments |
| (4,960 | ) | |||||
3,430 | (4,958 | ) | ||||||
Effect of exchange rates on cash |
(303 | ) | (37 | ) | ||||
Increase in cash and equivalents |
2,197 | 1,470 | ||||||
Cash and equivalents at beginning of period |
122,111 | 28,162 | ||||||
Cash and equivalents at end of period |
$ | 124,308 | $ | 29,632 | ||||
Supplemental Disclosures of Cash Flow Information |
||||||||
Cash paid: |
||||||||
Interest, net |
$ | 31,497 | $ | 16,125 | ||||
Income taxes, net |
2,299 | 6,324 | ||||||
Non-cash activity: |
||||||||
Capital contribution by parent |
| 4,250 |
See Notes to Condensed Consolidated Financial Statements
6
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS DEFICIT (Unaudited)
BORDEN CHEMICAL, INC.
(In thousands)
Common Stock |
Paid-in Capital |
Treasury Stock |
Receivable from Parent |
Accumulated Other Comprehensive Loss |
Accumulated Deficit |
Total |
||||||||||||||||||||
Balance, December 31, 2004 |
$ | 969 | $ | 1,274,358 | $ | (295,881 | ) | $ | (560,672 | ) | $ | (107,493 | ) | $ | (860,106 | ) | $ | (548,825 | ) | |||||||
Net loss |
(4,262 | ) | (4,262 | ) | ||||||||||||||||||||||
Translation adjustments |
(2,065 | ) | (2,065 | ) | ||||||||||||||||||||||
Comprehensive loss |
(6,327 | ) | ||||||||||||||||||||||||
Interest accrued on notes from parent |
12,144 | (12,144 | ) | | ||||||||||||||||||||||
Compensation expense on BHI Acquisition deferred compensation plan |
241 | 241 | ||||||||||||||||||||||||
Balance, March 31, 2005 |
$ | 969 | $ | 1,286,743 | $ | (295,881 | ) | $ | (572,816 | ) | $ | (109,558 | ) | $ | (864,368 | ) | $ | (554,911 | ) | |||||||
See Notes to Condensed Consolidated Financial Statements
7
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Dollars in thousands, except per share amounts and as otherwise indicated)
1. Background and Nature of Operations
Borden Chemical, Inc. (the Company) was incorporated on April 24, 1899. The Company is engaged primarily in manufacturing, processing, purchasing and distributing forest products and industrial resins, formaldehyde, oilfield products, UV coatings and other specialty and industrial chemicals worldwide. Production facilities are located throughout the U.S. and in many foreign countries.
In the third quarter of 2004, the Company was acquired by an affiliate of Apollo Management, L.P. (Apollo). The Companys immediate parent is BHI Acquisition Corp. (BHI Acquisition), which is a wholly owned subsidiary of BHI Investment LLC, an entity controlled by Apollo. The transactions related to the acquisition of the Company by Apollo are referred to collectively as the Apollo Transaction.
Prior to the Apollo Transaction, the Company was controlled by an affiliate of Kohlberg Kravis Roberts & Co. (KKR) since 1995.
The Company has three reportable segments: Forest Products, Performance Resins and International. See Note 10.
The Company has incurred approximately $9,100 of direct costs in connection with the Bakelite Acquisition (see Note 12), during the three months ended March 31, 2005, primarily for accounting and legal fees. In accordance with Statement of Financial Accounting Standards (SFAS) No. 141, Business Combinations, these amounts will be capitalized as part of the purchase price of the acquisition. Accordingly, these direct costs have been deferred on the March 31, 2005 Condensed Consolidated Balance Sheet in Other assets.
In addition, the Company has incurred costs totaling approximately $1,500 in connection with the Hexion Combination (see Note 12), during the three months ended March 31, 2005, primarily for accounting and legal fees. As this transaction is considered a merger of entities under common control, in accordance with SFAS 141, these costs have been expensed as incurred and are included in the 2005 Condensed Consolidated Statement of Operations as Transaction related costs.
2. Basis of Presentation
The accompanying unaudited Condensed Consolidated Financial Statements include the accounts of Borden Chemical, Inc. and its subsidiaries after elimination of intercompany accounts and transactions and contain all adjustments (which, except as otherwise noted, are of a normal, recurring nature), which in the opinion of management are necessary for a fair presentation of the results for the interim periods. Results for the interim periods are not necessarily indicative of results for the full year.
Stock-Based Compensation Effective January 1, 2005, the Company elected to adopt SFAS No. 123(R) (revised 2004), Share-Based Payment. Under the provisions of SFAS No. 123(R), stock-based compensation cost is measured at the grant date based on the value of the award and is recognized as expense over the vesting period. As the Company is considered a nonpublic entity that used the minimum value method for pro forma disclosures under SFAS No. 123, Accounting for Stock-Based Compensation, the Company is required to apply the prospective transition method. As such, the Company applies the statement to any new awards and to any awards modified, repurchased or cancelled since January 1, 2005. The Company will continue to account for awards outstanding at January 1, 2005 using the accounting principles originally applied to those awards, Accounting Principles Board Opinion No. 25, Accounting for Stock Issued to Employees. The adoption of SFAS No. 123(R) had no effect on the Companys financial condition and results of operations. There were no new awards, award modifications, repurchases or cancellations during the three months ended March 31, 2005.
Earnings Per Share Basic and diluted net (loss) income per share is computed by dividing net (loss) income by the weighted average number of common shares outstanding during the period including the effect of dilutive options, when applicable. The Company had no potentially dilutive instruments outstanding at March 31, 2005. At March 31, 2004, 5,657,930 options to purchase common shares of the Company were outstanding, of which 1,492,000 were considered dilutive. In addition, there were 1,587,301 shares of unvested restricted stock outstanding, which were dilutive.
8
The Companys diluted EPS is calculated as follows:
2005 |
2004 | ||||||
Net (loss) income applicable to common shareholders |
$ | (4,262 | ) | $ | 4,914 | ||
Average shares outstanding (in thousands) -basic |
96,906 | 199,308 | |||||
Effect of dilutive options (in thousands) |
| 1,141 | |||||
Average shares outstanding (in thousands) - diluted |
96,906 | 200,449 | |||||
Diluted EPS |
$ | (0.04 | ) | $ | 0.02 | ||
Reclassification The Company has reclassified reported amounts on the 2004 Condensed Consolidated Statement of Operations from Cost of goods sold to General & administrative expense and Distribution expense to conform with the current year presentation. The reclassification increased Cost of goods sold by $712 and decreased General & administrative expense and Distribution expense by $535 and $177, respectively.
3. Sale of Venture Interest
In 2001, the Company merged its North American foundry resins and coatings businesses with similar businesses of Delta-HA, Inc. (Delta) to form HA-International, LLC (HAI), in which the Company had a 75% interest at that time. The Limited Liability Agreement of HAI provides Delta the right to purchase between 3-5% of additional interest in HAI each year, beginning in 2004. Delta is limited to acquiring a maximum of 25% of additional interest in HAI under this arrangement. Pursuant to this provision, Delta has purchased a 10% interest in HAI from the Company, 5% during the third quarter of 2004 and 5% during the first quarter 2005, reducing the Companys interest in HAI to 65%.
Deltas purchase price of the interest is based on the enterprise value of HAI determined by applying a contractually agreed upon multiple to EBITDA, as defined in the agreement. The Company received cash proceeds of $2,507, as determined by the agreement, and recorded a gain of $1,614 related to the sale, which is included in Other operating (income) expense in the 2005 Condensed Consolidated Statement of Operations.
4. Business Realignment
In June 2003, the Company initiated a realignment program (the 2003 realignment program) designed to reduce operating expenses and increase organizational efficiency. The components of this program include reducing headcount, streamlining processes, consolidating manufacturing processes and reducing general and administrative expenses. We expect to complete this program in 2005 and will incur additional expenses through its completion. In addition, we have certain additional long-term realignment programs initiated prior to 2003 (the prior years programs), which primarily relate to consolidation of plant facilities.
Three months ended March 31, 2005
In the first quarter of 2005, the Company recorded business realignment and impairments income of $382, consisting of plant closure costs (which include plant employee severance and plant asset impairments) of $527 and other severance costs of $96 offset by a gain on the sale of assets of $1,005.
Plant Closure Costs
Plant closure costs in the first quarter of 2005 include $365 for the 2003 realignment program and $162 for prior years programs. The 2003 realignment program expense of $365 relates primarily to costs associated with a plant closing due to changes in the Companys manufacturing footprint and with the transition of manufacturing from the Companys North Bay, Ontario plant to another facility. Costs relating to prior years programs include environmental remediation of $71 for closed plants in Brazil and other plant closure costs of $91.
Other Severance Costs
The other severance costs incurred by the Company in the first quarter of 2005 were for workforce reductions related to the 2003 realignment program.
9
Gain on the Sale of Assets
In a prior year, the Company recorded an impairment charge on certain assets of its U.K. business, based on the assets net realizable value under a pending transaction. Although this transaction did not occur, the Company subsequently sold a portion of these assets in the first quarter of 2005 and recognized a gain of $1,005.
Provided below is a rollforward of the business realignment reserves for the first quarter of 2005.
Reserves December 31, 2004 |
2005 Expense |
2005 Settlements/ Charges |
Reserves March 31, 2005 | ||||||||||
Plant closure costs |
|||||||||||||
2003 realignment program |
$ | 238 | $ | 365 | $ | (166 | ) | $ | 437 | ||||
Prior years programs |
3,656 | 162 | (791 | ) | 3,027 | ||||||||
Other severance costs |
|||||||||||||
2003 realignment program |
646 | 96 | (191 | ) | 551 | ||||||||
$ | 4,540 | $ | 623 | $ | (1,148 | ) | $ | 4,015 | |||||
Three months ended March 31, 2004
In the first quarter of 2004, the Company recorded business realignment expense of $1,494, consisting of plant closure costs (which include plant employee severance and plant asset impairments) of $757 and other severance and employee costs of $737.
Plant Closure Costs
Plant closure costs in the first quarter of 2004 include $331 for the 2003 realignment program and $426 for prior years programs. The 2003 realignment program expense of $331 relates primarily to the conversion of the Companys manufacturing facility in France to a distribution center and the transition of the related manufacturing to the U.K. Costs relating to prior years programs include environmental remediation of $238 for closed plants in Brazil and other plant closure costs of $188.
Other Severance Costs
The other severance costs incurred by the Company in the first quarter of 2004 were for workforce reductions related to the 2003 realignment program.
Provided below is a rollforward of the business realignment reserves for the first quarter of 2004.
Reserves December 31, 2003 |
2004 Expense |
2004 Settlements/ Charges |
Reserves March 31, 2004 | ||||||||||
Plant closure costs |
|||||||||||||
2003 realignment program |
$ | 3,488 | $ | 331 | $ | (1,833 | ) | $ | 1,986 | ||||
Prior years programs |
4,741 | 426 | (563 | ) | 4,604 | ||||||||
Other severance costs |
|||||||||||||
2003 realignment program |
2,784 | 737 | (536 | ) | 2,985 | ||||||||
Prior years programs |
1,151 | | (1,151 | ) | | ||||||||
$ | 12,164 | $ | 1,494 | $ | (4,083 | ) | $ | 9,575 | |||||
10
5. Related Party Transactions
Administrative Service, Management and Consulting Arrangements
In connection with the Apollo Transaction, the Company entered into a transaction fee agreement with Apollo and its affiliates for the provision of certain structuring and advisory services. The agreement allows Apollo and its affiliates to provide certain advisory services to the Company for a seven-year period, with an automatic extension of the term for a one-year period beginning on the fourth anniversary of the commencement of the agreement and at the end of each year thereafter, unless notice to the contrary is given by either party. Under the agreement, the Company has also agreed to indemnify Apollo and its affiliates and their directors, officers and representatives for potential losses relating to the services contemplated under this agreement. The agreement, as later supplemented, provides for an annual fee of $2,500 for each annual period after January 1, 2005. The Company has paid the $2,500 annual fee for 2005. In the first quarter of 2005, the Company expensed $625 of fees pursuant to the agreement. The remaining $1,875 is included in Other current assets on the Condensed Consolidated Balance Sheet at March 31, 2005.
Prior to the Apollo Transaction, KKR provided certain management, consulting and board services to the Company for an annual fixed fee. During the quarter ended March 31, 2004, the Company recorded fees of $750 for the amount due to KKR under this arrangement.
Prior to the Apollo Transaction, the Company provided certain administrative services to BW Holdings, LLC, a former affiliate, and other former affiliates under a service agreement. For the three months ended March 31, 2004, the Company charged these former affiliates $122 for these services.
Other Transactions and Arrangements
The Company sells finished goods to certain Apollo affiliates. These sales totaled $1,936 for the three months ended March 31, 2005. Accounts receivable from these Apollo affiliates totaled $1,549 at March 31, 2005. In addition, the Company purchases finished goods from certain Apollo affiliates. These purchases totaled $569 for the three months ended March 31, 2005. Accounts payable to these Apollo affiliates totaled $123 at March 31, 2005.
In the first quarter of 2005, the Company received a payment of $7,500 from KKR for adjustments made to the purchase price of the Company in the Apollo Transaction. As the Company will pay this amount to BHI Acquisition in the second quarter of 2005, the balance is included in Other current liabilities on the Condensed Consolidated Balance Sheet at March 31, 2005
Prior to the Apollo Transaction, the Company utilized Willis Group Holdings, Ltd. (Willis), an entity controlled by KKR, as its insurance broker. In the first quarter of 2004, the Company paid $405 to Willis for their services.
6. Deal Contingent Forward
On December 14, 2004, the Company entered into a foreign currency forward position of $235 million to purchase Euros with U.S. Dollars at a rate of 1.3430. The contract was contingent upon the close of the Bakelite Aktiengesellschaft (Bakelite) share purchase agreement (see Note 12). On March 31, 2005, the Company adjusted the contract to have a target settlement date of April 29, 2005 and a new foreign exchange rate of 1.3446. The purpose of the forward was to mitigate the risk of foreign currency exposure related to the transaction. At March 31, 2005, the Company recorded an unrealized loss of $10,432 related to the contingent forward contract, which is included as Other non-operating expense in the 2005 Condensed Consolidated Statement of Operations. On April 29, 2005, upon the close of the Bakelite share purchase agreement, the Company recorded a realized loss of approximately $9,200.
7. Guarantees, Indemnifications and Warranties
Standard Guarantees / Indemnifications
In the ordinary course of business, the Company enters into numerous agreements that contain standard guarantees and indemnities whereby the Company indemnifies another party for, among other things, breaches of representations and warranties. Such guarantees or indemnifications are granted under various agreements, including those governing (i) purchases and sales of assets or businesses, (ii) leases of real property, (iii) licenses of intellectual property and (iv) long-term supply agreements. The guarantees or indemnifications issued are for the benefit of the (i) buyers in sale agreements and sellers in purchase agreements, (ii) landlords or lessors in lease contracts, (iii) licensors or licensees in license agreements and (iv) vendors or customers in long-term supply agreements.
11
These parties may also be indemnified against any third party claim resulting from the transaction that is contemplated in the underlying agreement. Additionally, in connection with the sale of assets and the divestiture of businesses, the Company may agree to indemnify the buyer with respect to liabilities related to the pre-closing operations of the assets or businesses sold. Indemnities related to pre-closing operations generally include tax liabilities, environmental liabilities and employee benefit liabilities not assumed by the buyer in the transaction.
Indemnities related to the pre-closing operations of sold assets normally do not represent additional liabilities to the Company, but simply serve to protect the buyer from potential liability associated with the Companys existing obligations at the time of sale. As with any liability, the Company has accrued for those pre-closing obligations that are considered probable and reasonably estimable. Amounts recorded are not significant at March 31, 2005.
While some of these guarantees extend only for the duration of the underlying agreement, many survive the expiration of the term of the agreement or extend into perpetuity (unless subject to a legal statute of limitations). There are no specific limitations on the maximum potential amount of future payments that the Company could be required to make under these guarantees nor is the Company able to develop an estimate of the maximum potential amount of future payments to be made under these guarantees as the triggering events are not predictable. With respect to certain of the aforementioned guarantees, the Company maintains limited insurance coverage that mitigates potential payments to be made. The Company had limited reimbursement agreements from affiliates that were terminated as a result of the Apollo Transaction.
In connection with the Apollo Transaction, the Company entered into a transaction fee agreement with Apollo and its affiliates for the provision of certain structuring and advisory services. The Company has agreed to indemnify Apollo and its affiliates and their directors, officers and representatives for potential losses relating to the services contemplated under this agreement.
In addition, the Company had previously agreed to indemnify KKR for any claims resulting from its services to the Company and its affiliates. The indemnification was terminated as a result of the Apollo Transaction.
The Company has not entered into any significant agreement subsequent to January 1, 2003 that would require it, as a guarantor, to recognize a liability for the fair value of obligations it has undertaken in issuing the guarantee.
Warranties
The Company does not make express warranties on its products, other than that they comply with the Companys specifications; therefore, the Company does not record a warranty liability. Adjustments for product quality claims are not material and are charged against sales revenues.
8. Commitments and Contingencies
Environmental Matters
Because the Companys operations involve the use, handling, processing, storage, transportation and disposal of hazardous materials, the Company is subject to extensive environmental regulation at the Federal and state level and is exposed to the risk of claims for environmental remediation or restoration. In addition, violations of environmental laws or permits may result in restrictions being imposed on operating activities, substantial fines, penalties, damages or other costs, any of which could have a material adverse effect on the Companys business, financial condition, results of operations or cash flows.
Accruals for environmental matters are recorded following the guidelines of Statement of Position 96-1, Environmental Remediation Liabilities, when it is probable that a liability has been incurred and the amount of the liability can be estimated. Environmental accruals are reviewed on an interim basis and as events and developments warrant. Based on managements estimates, which are determined through historical experience and consultation with outside experts, the Company has recorded liabilities, relating to 57 locations, of approximately $37,200 and $38,200 at March 31, 2005 and December 31, 2004, respectively, for all probable environmental remediation, indemnification and restoration liabilities. These amounts include estimates of unasserted claims the Company believes are probable of loss and reasonably
12
estimable. Based on the factors discussed below and currently available information and analysis, the Company believes that it is reasonably possible that costs associated with such sites may fall within a range of $24,900 to $77,400, in the aggregate, at March 31, 2005. This estimate of the range of reasonably possible costs is less certain than the estimates upon which the liabilities are based, and in order to establish the upper end of such range, assumptions less favorable to the Company among the range of reasonably possible outcomes were used. As with any estimate, if facts or circumstances change, the final outcome could differ materially from these estimates. The Company has not taken into consideration insurance coverage or any anticipated recoveries from other third parties in determining the liability or range of possible outcomes. The Companys current insurance coverage provides very limited, if any, coverage for environmental matters.
Following is a more detailed discussion of the Companys environmental liabilities and related assumptions:
BCP Geismar Site The Company formerly owned a basic chemicals and polyvinyl chloride business which was taken public as Borden Chemicals and Plastics Operating Limited Partnership (BCPOLP) in 1987. The Company retained a 1% interest and the general partner interest, which were held by its subsidiary, BCPM. The Company also retained the liability for certain environmental matters after BCPOLPs formation. Under a Settlement Agreement approved by the United States Bankruptcy Court for the District of Delaware among the Company, BCPOLP, BCPM, the United States Environmental Protection Agency (EPA) and the Louisiana Department of Environmental Quality, the Company agreed to perform certain of BCPOLPs obligations with respect to environmental conditions at BCPOLPs Geismar, Louisiana site. These obligations are related to soil and groundwater contamination at the Geismar site. The Company bears the sole responsibility for these obligations, as there are no other potentially responsible parties (PRPs) or third parties from which the Company can seek reimbursement, and no additional insurance recoveries are expected.
A groundwater pump and treat system for the removal of contaminants is operational, and preliminary natural attenuation studies are proceeding. The Company has performed extensive soil and groundwater testing. Regulatory agencies are reviewing the current findings and remediation efforts. If closure procedures and remediation systems prove inadequate, or if additional contamination is discovered, this could result in the costs approaching the higher end of the range of possible outcomes discussed below.
The Company has recorded a liability of approximately $20,600 and $21,100 at March 31, 2005 and December 31, 2004, respectively, related to the BCP Geismar site. Based on currently available information and analysis, the Company believes that it is reasonably possible that costs associated with this site may fall within a range of $13,900 to $32,100, depending upon the factors discussed above. Due to the long-term nature of the project, the reliability of timing and the ability to estimate remediation payments, this liability was recorded at its net present value, assuming a 3% discount rate and a time period of thirty years and the range of possible outcomes is discounted similarly. The undiscounted liability is approximately $31,500 over thirty years.
Following are expected payments for each of the next five years, and a reconciliation of the expected aggregate payments to the liability reflected at March 31, 2005:
2005 |
$ | 2,000 | ||
2006 |
1,600 | |||
2007 |
1,600 | |||
2008 |
1,500 | |||
2009 |
700 | |||
Remaining aggregate payments |
24,100 | |||
Total undiscounted liability |
31,500 | |||
Less: discount to net present value |
(10,900 | ) | ||
Liability per Consolidated Balance Sheet |
$ | 20,600 | ||
Superfund Sites / Offsite Landfills - The Company is currently involved in environmental remediation activities at 28 sites in which it has been notified that it is, or may be, a PRP under the United States Comprehensive Environmental Response, Compensation and Liability Act (CERCLA) or similar state superfund laws. The Company has recorded liabilities of approximately $8,100 and $7,900 at March 31, 2005 and December 31, 2004, respectively, related to these sites. The Company anticipates approximately 60% of this liability will be paid within the next five years, with the remaining payments occurring over the next twenty-five years. The Company
13
generally does not bear a significant level of responsibility for these sites, and therefore, has little control over the costs and timing of cash flows. At 16 of the 28 sites, the Companys share is less than 1%. At the remaining 12 sites, the Company has a share of up to 8.8% of the total liability which accounts for $6,900 and $6,700 of the total amount reserved for superfund / offsite landfill sites at March 31, 2005 and December 31, 2004, respectively. Based on currently available information and analysis, the Company believes that it is reasonably possible that costs associated with all superfund sites may be as low as $5,300 or as high as $17,800, in the aggregate. In estimating both its current reserves for environmental remediation at these sites and the possible range of additional costs, the Company has not assumed that it will bear the entire cost of remediation of every site to the exclusion of other known PRPs who may be jointly and severally liable. The Company has limited information to assess the viability of other PRPs and their probable contribution on a per site basis. The range of possible outcomes also takes into account the maturity of each project, which results in a more narrow range as the project progresses. The Companys ultimate liability will depend on many factors including its volumetric share of waste, the financial viability of other PRPs, the remediation methods and technology used, the amount of time necessary to accomplish remediation, and the availability of insurance coverage. The Companys insurance provides very limited, if any, coverage for these environmental matters.
Sites Under Current Ownership - The Company is conducting environmental remediation at 5 locations currently owned by the Company, of which 2 sites are no longer operating. There are no other parties responsible for remediation at these sites. Much of the remediation is being performed by the Company on a voluntary basis; therefore, the Company has greater control over the costs to be incurred and the timing of cash flows. The Company has accrued approximately $4,000 and $5,400 at March 31, 2005 and December 31, 2004, respectively, for remediation and restoration liabilities at these locations. The Company anticipates approximately $3,700 of these liabilities will be paid within the next three years, with the remaining amounts being paid over the next ten years. Approximately $3,000 of these reserves is included in the Companys business realignment reserve, as the environmental clean up is being handled in conjunction with planned closure of the location (see Note 4). Based on currently available information and analysis, the Company believes that it is reasonably possible that costs associated with such sites may fall within a range of $2,600 to $11,600, in the aggregate. The factors influencing the ultimate outcome include the methods of remediation to be elected, the conclusions and assessment of site studies remaining to be completed and the time period required to complete the work.
Other Sites - The Company is conducting environmental remediation at 10 locations formerly owned by the Company. The Company has accrued approximately $3,200 and $2,500 at March 31, 2005 and December 31, 2004, respectively, for remediation and restoration liabilities at these locations. The Company anticipates cash outflows of approximately $2,000 within the next three years, with the remainder occurring over the next ten years. Based on currently available information and analysis, the Company believes that it is reasonably possible that costs associated with such sites may fall within a range of $2,400 to $13,800, in the aggregate. The primary drivers in determining the final costs to the Company on these matters are the method of remediation selected and the level of participation of third parties.
In addition, the Company is responsible for 12 sites that require monitoring where no additional remediation is expected and has also established accruals for other related costs, such as fines and penalties. The Company has accrued approximately $1,300 at March 31, 2005 and December 31, 2004, related to these sites. Payment of these liabilities is anticipated to occur over the next ten years. Based on currently available information and analysis, the Company believes that it is reasonably possible that costs associated with such sites may fall within a range of $700 and $2,100, in the aggregate. The ultimate cost to the Company will be influenced by any variations in projected monitoring periods or by findings that are better or worse than anticipated findings.
The Company formerly operated the Smith Douglass fertilizer business which included a phosphate processing operation in Manatee County, Florida and an animal food processing operation in Hillsborough County, Florida. Both operations were sold in 1980. The EPA has sent the Company and another former owner of the Manatee County facility a request for $112 relating to oversight costs incurred when the site was abandoned by its current owner. The Company is disputing the charge. The Company is aware that state and Federal environmental agencies have taken measures to prevent the off-site release of water from rainfall that accumulated in the drainage ditches and lagoons surrounding the gypsum piles located on this site. The Company is aware that the current owner of the Hillsborough County site ceased operations in March of 2004 and is working with governmental agencies to effect closure of that site. At this time, the Company has received an information
14
request from the EPA, but has not received any demands from any governmental agencies or others regarding the closure and environmental cleanup at this site, which the Company believes is the responsibility of the current owner. While it is reasonably possible some costs could be incurred related to these sites, the Company has inadequate information to enable it to estimate a potential range of liability, if any. As of March 31, 2005, the Company had a reserve of $63 relating to these matters.
Non-Environmental Legal Matters
Following is a discussion of non-environmental legal proceedings that are not in the ordinary course of business:
Imperial Home Décor Group - In 1998, pursuant to a merger and recapitalization transaction sponsored by The Blackstone Group (Blackstone) and financing arranged by The Chase Manhattan Bank (Chase), Borden Decorative Products Holdings, Inc. (BDPH), a wholly owned subsidiary of the Company, was acquired by Blackstone and subsequently merged with Imperial Wallcoverings to create Imperial Home Décor Group (IHDG). Blackstone provided $84,500 in equity, a syndicate of banks funded $198,000 of senior secured financing and $125,000 of senior subordinated notes were privately placed. The Company received approximately $309,000 in cash and 11% of IHDG common stock for its interest in BDPH at the closing of the merger. On January 5, 2000, IHDG filed for reorganization under Chapter 11 of the U. S. Bankruptcy Code. The IHDG Litigation Trust (the Trust) was created pursuant to the plan of reorganization in the IHDG bankruptcy to pursue preference and other avoidance claims on behalf of the unsecured creditors of IHDG. In November 2001, the Trust filed a lawsuit against the Company and certain of its affiliates in U.S. Bankruptcy Court in Delaware seeking to have the IHDG recapitalization transaction voided as a fraudulent conveyance and asking for a judgment to be entered against the Company for $314,400 plus interest, costs and attorney fees. An effort to resolve this matter through non-binding mediation was unsuccessful in resolving the case and the parties are preparing for trial.
The Company has an accrual of $2,300 for legal defense costs related to this matter. The Company has not recorded a liability for any potential losses because a loss is not considered probable based on current information. The Company believes it has strong defenses to the Trusts allegations and intends to defend the case vigorously. While it is reasonably possible the resolution of this matter may result in a loss due to the many variables involved, the Company is not able to estimate the range of possible outcomes at this time.
Brazil Tax Claim - In 1992, the State of Sao Paulo Administrative Tax Bureau issued an assessment against the Companys primary Brazilian subsidiary claiming that excise taxes were owed on certain intercompany loans made for centralized cash management purposes, characterized by the Tax Bureau as intercompany sales. Since that time, management and the Tax Bureau have held discussions, and the subsidiary has filed an administrative appeal seeking cancellation of the assessment. The Administrative Court upheld the assessment in December 2001. In 2002, the subsidiary filed a second appeal with the highest-level Administrative Court, again seeking cancellation of the assessment. Argument was made to the court in September 2004 and the Company is awaiting its ruling.
At March 31, 2005, the amount of the assessment, including tax, penalties, monetary correction and interest, is 63.3 million Brazilian Reais, or approximately $23,700. The Company believes it has a strong defense against the assessment and will pursue the appeal vigorously, including appealing to the judicial level; however, there is no assurance that the assessment will not be upheld. At this time the Company does not believe a loss is probable; therefore, only related legal fees have been accrued. Reasonably possible losses to the Company resulting from the resolution of this matter range from zero to $23,700.
HAI Grand Jury Investigation HAI received a grand jury subpoena dated November 5, 2003 from the U.S. Department of Justice Antitrust Division relating to a foundry resins Grand Jury investigation. HAI has provided documentation in response to the subpoena. As is frequently the case when such investigations are in progress, various antitrust lawsuits have been brought against the Company alleging that the Company and HAI, along with various other entities, engaged in a price fixing conspiracy. At this time the Company does not believe a loss is probable; therefore, only related legal fees have been accrued. The Company does not have sufficient information to determine a range of possible outcomes for this matter at this time.
15
CTA Acoustics From the third quarter 2003 to the first quarter 2004, six lawsuits were filed against the Company in the 27th Judicial District, Laurel County Circuit Court, in Kentucky, arising from an explosion at a customers plant where seven plant workers were killed and over 40 other workers were injured. The lawsuits primarily seek recovery for wrongful death, emotional and personal injury, loss of consortium, property damage and indemnity. The Company expects that a number of these suits will be consolidated. The litigation also includes claims by its customer against its insurer and the Company. The Company is pursuing a claim for indemnity against its customer, based on language in its contract with the customer, and a claim against a third party that performed services for the Company in connection with sales to the customer. The Company previously accrued $5,000, the amount of its insurance deductible, relating to these actions and has insurance coverage to address any payments and legal fees in excess of this amount.
Other Legal Matters - The Company has been served in two lawsuits filed in Hillsborough County, Florida Circuit Court which name the Company and several other parties, relating to an animal feed supplement processing site formerly operated by the Company and sold in 1980. The lawsuits are filed on behalf of multiple residents of Hillsborough County living near the site and allege various injuries related to exposure to toxic chemicals. At this time, the Company has inadequate information from which to estimate a potential range of liability, if any.
The Company is involved in various product liability, commercial and employment litigation, personal injury, property damage and other legal proceedings which are considered to be in the ordinary course of business. There has been increased publicity about asbestos liabilities faced by manufacturing companies. In large part, as a result of the bankruptcies of many asbestos producers, plaintiffs attorneys are increasing their focus on peripheral defendants, including the Company, and asserting that even products that contained a small amount of asbestos caused injury. Plaintiffs are also focusing on alleged harm caused by other products we have made or used, including those containing silica and vinyl chloride monomer. The Company does not believe that it has a material exposure relating to these claims and believes it has adequate reserves and insurance to cover currently pending and foreseeable future claims.
The Company has reserved approximately $16,700 and $19,800 at March 31, 2005 and December 31, 2004, respectively, relating to all non-environmental legal matters for legal defense and settlement costs that it believes are probable and estimable at this time.
Other Commitments and Contingencies
The Limited Liability Agreement of HAI provides Delta the right to purchase between 3-5% of additional interest in HAI each year, beginning in 2004. Delta is limited to acquiring a maximum of 25% of additional interest in HAI under this arrangement. Pursuant to this provision, Delta has purchased a 10% interest in HAI from the Company, 5% during the third quarter of 2004 and 5% during the first quarter 2005, reducing the Companys interest in HAI to 65%. Deltas purchase price of the interest is based on the enterprise value of HAI determined by applying a contractually agreed upon multiple to EBITDA, as defined in the agreement. See Note 3.
The Fentak Pty. Ltd. acquisition agreement includes a contingent purchase consideration provision based on achievement of certain targeted earnings before interest and taxes. Maximum annual payments are AU$600 for the period 2005-2006.
16
9. Pension and Postretirement Expense
Following are the components of net pension and postretirement expense recognized by the Company for the periods ended March 31, 2005 and 2004:
Pension |
Postretirement |
|||||||||||||||
Three months ended March 31, |
Three months ended March 31, |
|||||||||||||||
2005 |
2004 |
2005 |
2004 |
|||||||||||||
Service cost |
$ | 872 | $ | 746 | $ | 34 | $ | 19 | ||||||||
Interest cost |
3,355 | 3,480 | 252 | 369 | ||||||||||||
Expected return on plan assets |
(4,036 | ) | (4,157 | ) | | | ||||||||||
Amortization |
||||||||||||||||
Prior service cost |
74 | 109 | (2,795 | ) | (2,589 | ) | ||||||||||
Recognized net actuarial loss |
1,669 | 1,608 | (144 | ) | | |||||||||||
$ | 1,934 | $ | 1,786 | $ | (2,653 | ) | $ | (2,201 | ) | |||||||
The amortization of prior service cost included in the postretirement benefit relates to the plan amendments made in 2004 and 2003.
10. Segment Data
The Company consists of three reportable segments: Forest Products, Performance Resins and International. Consolidated results also include Corporate and Other, which is reported separately. The product lines included in the Forest Products segment are formaldehyde and forest product resins. The key business drivers in the Forest Products segment are housing starts, furniture demand, panel production capacity and chemical sector operating conditions. The Performance Resins segment includes oilfield, foundry and specialty resins. In the Performance Resins segment, the key business drivers are housing starts, auto builds, active gas drilling rigs and the general industrial sector. The International segment consists of operations in Europe, Latin America and Asia Pacific. Principal countries of operation are the U.K., Brazil, Australia and Malaysia. Product lines include formaldehyde, forest product and performance resins and consumer products. In the International segment, the key business drivers are export levels, panel production capacity, housing starts, furniture demand and the local political environment. Corporate and Other represents general and administrative expenses and income and expenses related to liabilities retained from businesses sold in previous years.
Operating Results by Segment:
Following is a comparison of net sales and Segment EBITDA. Segment EBITDA is equal to income (loss) before depreciation and amortization, interest expense, other non-operating expenses or income, income taxes and other adjustments (which include costs included in operating income associated with the Apollo Transaction, business realignment activities, certain costs primarily related to legacy businesses, dispositions and pension settlement charges, if any). Segment EBITDA is presented by reportable segment and for Corporate and Other of the Company for the three months ended March 31, 2005 and 2004. Segment EBITDA information is presented with the Companys segment disclosures because it is the measure used by the Companys management in the evaluation of operating results and in determining allocations of capital resources among the business segments. It is also the metric used by the Company to set management and executive incentive compensation.
Net Sales | ||||||
2005 |
2004 | |||||
Forest Products |
$ | 256,082 | $ | 194,667 | ||
Performance Resins |
123,054 | $ | 101,964 | |||
International |
106,030 | 88,803 | ||||
$ | 485,166 | $ | 385,434 | |||
17
Segment EBITDA | ||||||||
2005 |
2004 |
|||||||
Forest Products |
$ | 28,399 | $ | 23,721 | ||||
Performance Resins |
15,382 | 11,019 | ||||||
International |
10,648 | 9,029 | ||||||
Corporate and Other |
(10,167 | ) | (8,922 | ) | ||||
$ | 44,262 | $ | 34,847 | |||||
The table below reconciles Segment EBITDA to net (loss) income, which management believes to be the most directly comparable GAAP financial measure.
Reconciliation of Segment EBITDA to Net (Loss) Income | ||||||||
Three Months ended March 31, |
||||||||
2005 |
2004 |
|||||||
Segment EBITDA |
$ | 44,262 | $ | 34,847 | ||||
Depreciation and amortization |
(12,360 | ) | (11,943 | ) | ||||
Adjustments to Segment EBITDA (described below) |
67 | (2,102 | ) | |||||
Interest expense |
(21,785 | ) | (11,890 | ) | ||||
Other non-operating expense |
(9,113 | ) | (61 | ) | ||||
Income tax expense |
(5,333 | ) | (3,937 | ) | ||||
Net (loss) income |
$ | (4,262 | ) | $ | 4,914 | |||
Adjustments to Segment EBITDA
The following items are not included in Segment EBITDA:
Three months ended March 31, 2005 |
Plant Closure(1) |
Severance |
Other |
Total |
||||||||||||
Forest Products |
$ | (196 | ) | $ | | $ | | $ | (196 | ) | ||||||
Performance Resins |
(215 | ) | | 1,614 | (2) | 1,399 | ||||||||||
International |
(116 | ) | | 1,005 | (3) | 889 | ||||||||||
Corporate and Other |
| (96 | ) | (1,929 | )(4) | (2,025 | ) | |||||||||
$ | (527 | ) | $ | (96 | ) | $ | 690 | $ | 67 | |||||||
(1) | Plant closure costs include fixed asset write-offs, plant employee severance and demolition, environmental and other related costs. |
(2) | Represents the gain on the sale of an additional 5% interest of HAI to Delta. See Note 3. |
(3) | Represents a gain on the sale of assets impaired in 2004. See Note 4. |
(4) | Primarily represents transaction costs associated with the Hexion Combination. See Note 1. |
Three months ended March 31, 2004 |
(1) Plant Closure |
Severance |
(2) Other |
Total |
||||||||||||
Forest Products |
$ | (22 | ) | $ | (274 | ) | $ | (39 | ) | $ | (335 | ) | ||||
International |
(748 | ) | (153 | ) | | (901 | ) | |||||||||
Corporate and Other |
13 | (310 | ) | (569 | ) | (866 | ) | |||||||||
$ | (757 | ) | $ | (737 | ) | $ | (608 | ) | $ | (2,102 | ) | |||||
(1) | Plant closure costs include fixed asset write-offs, plant employee severance and demolition, environmental and other related costs. |
(2) | Primarily represents severance expense, included in general and administrative expense, incurred by the Company for positions to be replaced. |
18
11. Guarantor/Non-Guarantor Subsidiary Financial Information
In conjunction with the Apollo Transaction, the Company formed two wholly owned finance subsidiaries to borrow $475 million through a private debt offering. The Company and certain of its subsidiaries guarantee this debt. The following information contains the condensed consolidating financial information for the parent, Borden Chemical, Inc., the subsidiary issuers (Borden U.S. Finance Corporation and Borden Nova Scotia, ULC), the subsidiary guarantors (BDS Two, Inc., Borden Chemical Investments, Inc., Borden Chemical Foundry, Inc. and Borden Services Company) and the combined non-guarantor subsidiaries, which includes all of the Companys foreign subsidiaries and HAI. All of the subsidiary issuers and subsidiary guarantors are owned 100% by the Company. All guarantees are full and unconditional and are joint and several. There are no significant restrictions on the ability of the Company to obtain funds from its domestic subsidiaries by dividend or loan. While the Companys Australian subsidiary and HAI are restricted in the payment of dividends and intercompany loans due to the terms of their credit facilities, there are no material restrictions on the Companys ability to obtain cash from the remaining non-guarantor subsidiaries.
This information includes allocations of Corporate overhead to the combined non-guarantor subsidiaries based on Net sales. Income tax expense has been provided on the combined non-guarantor subsidiaries based on actual effective tax rates. All other tax expense is reflected in the parent.
19
BORDEN CHEMICAL, INC.
Notes to Condensed Consolidated Financial Statements
(Dollars in thousands)
THREE MONTHS ENDED MARCH 31, 2005
CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS
Borden Chemical, Inc. |
Subsidiary Issuers |
Combined Subsidiary Guarantors |
Combined Non- Guarantor Subsidiaries |
Eliminations |
Consolidated |
|||||||||||||||||||
Net sales |
$ | 286,061 | $ | | $ | | $ | 240,515 | $ | (41,410 | ) | $ | 485,166 | |||||||||||
Cost of goods sold |
240,903 | | | 195,816 | (41,410 | ) | 395,309 | |||||||||||||||||
Gross margin |
45,158 | | | 44,699 | | 89,857 | ||||||||||||||||||
Distribution expense |
12,182 | | | 9,163 | | 21,345 | ||||||||||||||||||
Marketing expense |
5,922 | | | 6,037 | | 11,959 | ||||||||||||||||||
General & administrative expense |
11,771 | | 63 | 11,911 | | 23,745 | ||||||||||||||||||
Transaction related costs |
791 | | | 709 | | 1,500 | ||||||||||||||||||
Business realignment and impairments (income) expense |
318 | | | (700 | ) | | (382 | ) | ||||||||||||||||
Other operating expense (income) |
1,689 | | (1,666 | ) | (302 | ) | | (279 | ) | |||||||||||||||
Operating income |
12,485 | | 1,603 | 17,881 | | 31,969 | ||||||||||||||||||
Interest expense |
9,651 | 10,599 | | 1,535 | | 21,785 | ||||||||||||||||||
Intercompany interest expense (income) |
57,648 | (11,342 | ) | (52,948 | ) | 6,642 | | | ||||||||||||||||
Intercompany royalty expense (income) |
5,779 | | (5,779 | ) | | | | |||||||||||||||||
Equity in (earnings) losses of subsidiaries, net |
(67,126 | ) | | (2,038 | ) | | 69,164 | | ||||||||||||||||
Other non-operating expense (income) |
9,183 | 990 | | (1,060 | ) | | 9,113 | |||||||||||||||||
Income (loss) before income tax |
(2,650 | ) | (247 | ) | 62,368 | 10,764 | (69,164 | ) | 1,071 | |||||||||||||||
Income tax expense |
1,612 | | | 3,721 | | 5,333 | ||||||||||||||||||
Net (loss) income |
$ | (4,262 | ) | $ | (247 | ) | $ | 62,368 | $ | 7,043 | $ | (69,164 | ) | $ | (4,262 | ) | ||||||||
20
BORDEN CHEMICAL, INC.
Notes to Condensed Consolidated Financial Statements
(Dollars in thousands)
THREE MONTHS ENDED MARCH 31, 2004
CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS
Borden Chemical, Inc. |
Subsidiary Issuers |
Combined Subsidiary Guarantors |
Combined Non- Guarantor Subsidiaries |
Eliminations |
Consolidated | |||||||||||||||||
Net sales |
$ | 226,547 | $ | | $ | | $ | 189,305 | $ | (30,418 | ) | $ | 385,434 | |||||||||
Cost of goods sold |
186,236 | | | 154,431 | (30,418 | ) | 310,249 | |||||||||||||||
Gross margin |
40,311 | | | 34,874 | | 75,185 | ||||||||||||||||
Distribution expense |
10,248 | | | 7,080 | | 17,328 | ||||||||||||||||
Marketing expense |
5,563 | | | 5,840 | | 11,403 | ||||||||||||||||
General & administrative expense |
10,769 | | 117 | 11,988 | | 22,874 | ||||||||||||||||
Business realignment expense and impairments |
441 | | | 1,053 | | 1,494 | ||||||||||||||||
Other operating expense (income) |
1,574 | | (25 | ) | (265 | ) | | 1,284 | ||||||||||||||
Operating income (loss) |
11,716 | | (92 | ) | 9,178 | | 20,802 | |||||||||||||||
Interest expense |
11,511 | | | 379 | | 11,890 | ||||||||||||||||
Intercompany interest expense (income) |
26,054 | | (26,325 | ) | 271 | | | |||||||||||||||
Intercompany royalty expense (income) |
4,688 | | (4,688 | ) | | | | |||||||||||||||
Equity in (earnings) losses of subsidiaries, net |
(35,787 | ) | | (1,281 | ) | | 37,068 | | ||||||||||||||
Other non-operating expense (income) |
617 | | | (556 | ) | | 61 | |||||||||||||||
Income before income tax |
4,633 | | 32,202 | 9,084 | (37,068 | ) | 8,851 | |||||||||||||||
Income tax expense (benefit) |
(281 | ) | | | 4,218 | | 3,937 | |||||||||||||||
Net income |
$ | 4,914 | $ | | $ | 32,202 | $ | 4,866 | $ | (37,068 | ) | $ | 4,914 | |||||||||
21
BORDEN CHEMICAL, INC.
Notes to Condensed Consolidated Financial Statements
(Dollars in thousands)
MARCH 31, 2005
CONDENSED CONSOLIDATING BALANCE SHEET
Borden Chemical, Inc. |
Subsidiary Issuers |
Combined Subsidiary Guarantors |
Combined Non- Guarantor Subsidiaries |
Eliminations |
Consolidated |
||||||||||||||||||
ASSETS |
|||||||||||||||||||||||
Current Assets |
|||||||||||||||||||||||
Cash and equivalents |
$ | 64,654 | $ | 46 | $ | 444 | $ | 59,164 | $ | | $ | 124,308 | |||||||||||
Accounts receivable |
84,296 | | 5,752 | 127,570 | | 217,618 | |||||||||||||||||
Intercompany accounts receivable |
23,525 | 9,656 | 7,683 | 6,940 | (47,804 | ) | | ||||||||||||||||
Inventories: |
|||||||||||||||||||||||
Finished & in-process goods |
30,350 | | | 23,658 | | 54,008 | |||||||||||||||||
Raw materials and supplies |
28,302 | | | 22,939 | | 51,241 | |||||||||||||||||
Other current assets |
11,865 | | | 4,423 | | 16,288 | |||||||||||||||||
242,992 | 9,702 | 13,879 | 244,694 | (47,804 | ) | 463,463 | |||||||||||||||||
Other Assets |
|||||||||||||||||||||||
Investment in subsidiaries |
6,304,528 | | 11,604 | | (6,316,132 | ) | | ||||||||||||||||
Loans receivable from affiliates |
480,970 | 6,211,207 | 40,511 | (6,732,688 | ) | | |||||||||||||||||
Other assets |
23,214 | 17,921 | | 21,192 | | 62,327 | |||||||||||||||||
6,327,742 | 498,891 | 6,222,811 | 61,703 | (13,048,820 | ) | 62,327 | |||||||||||||||||
Property and Equipment |
|||||||||||||||||||||||
Land |
24,347 | | | 8,827 | | 33,174 | |||||||||||||||||
Buildings |
65,857 | | | 37,636 | | 103,493 | |||||||||||||||||
Machinery and equipment |
420,271 | | 531 | 314,031 | | 734,833 | |||||||||||||||||
510,475 | | 531 | 360,494 | | 871,500 | ||||||||||||||||||
Less accumulated depreciation |
(271,840 | ) | | (485 | ) | (158,411 | ) | | (430,736 | ) | |||||||||||||
238,635 | | 46 | 202,083 | | 440,764 | ||||||||||||||||||
Goodwill |
34,491 | | | 15,964 | | 50,455 | |||||||||||||||||
Other intangible assets |
4,477 | | | 5,420 | | 9,897 | |||||||||||||||||
Total Assets |
$ | 6,848,337 | $ | 508,593 | $ | 6,236,736 | $ | 529,864 | $ | (13,096,624 | ) | $ | 1,026,906 | ||||||||||
LIABILITIES AND SHAREHOLDERS DEFICIT |
|||||||||||||||||||||||
Current Liabilities |
|||||||||||||||||||||||
Accounts and drafts payable |
$ | 114,633 | $ | | $ | 5 | $ | 93,678 | $ | | $ | 208,316 | |||||||||||
Intercompany accounts payable |
11,589 | 627 | 100 | 35,488 | (47,804 | ) | | ||||||||||||||||
Debt payable within one year |
1,794 | | | 6,387 | | 8,181 | |||||||||||||||||
Income taxes payable |
31,830 | | | 1,786 | | 33,616 | |||||||||||||||||
Interest payable |
7,466 | 8,480 | | 10 | | 15,956 | |||||||||||||||||
Other current liabilities |
63,316 | | 5,602 | 23,508 | | 92,426 | |||||||||||||||||
230,628 | 9,107 | 5,707 | 160,857 | (47,804 | ) | 358,495 | |||||||||||||||||
Other Liabilities |
|||||||||||||||||||||||
Long-term debt |
473,582 | 475,000 | | 6,575 | | 955,157 | |||||||||||||||||
Long-term intercompany loans payable |
6,448,959 | | | 283,729 | (6,732,688 | ) | | ||||||||||||||||
Non-pension postemployment benefit obligations |
109,329 | | | 1,495 | | 110,824 | |||||||||||||||||
Other long-term liabilities |
140,750 | | | 16,591 | | 157,341 | |||||||||||||||||
7,172,620 | 475,000 | | 308,390 | (6,732,688 | ) | 1,223,322 | |||||||||||||||||
Shareholders (Deficit) Equity |
(554,911 | ) | 24,486 | 6,231,029 | 60,617 | (6,316,132 | ) | (554,911 | ) | ||||||||||||||
Total Liabilities & Shareholders (Deficit) Equity |
$ | 6,848,337 | $ | 508,593 | $ | 6,236,736 | $ | 529,864 | $ | (13,096,624 | ) | $ | 1,026,906 | ||||||||||
22
BORDEN CHEMICAL, INC.
Notes to Condensed Consolidated Financial Statements
(Dollars in thousands)
DECEMBER 31, 2004
CONDENSED CONSOLIDATING BALANCE SHEET
Borden Chemical, Inc. |
Subsidiary Issuers |
Combined Subsidiary Guarantors |
Combined Non- Guarantor Subsidiaries |
Eliminations |
Consolidated |
||||||||||||||||||
ASSETS |
|||||||||||||||||||||||
Current Assets |
|||||||||||||||||||||||
Cash and equivalents |
$ | 55,199 | $ | 2 | $ | 600 | $ | 66,310 | $ | | $ | 122,111 | |||||||||||
Accounts receivable |
98,694 | | 209 | 127,332 | | 226,235 | |||||||||||||||||
Accounts receivable from affiliates |
24,927 | 15,494 | 7,684 | 6,734 | (54,839 | ) | | ||||||||||||||||
Inventories: |
| ||||||||||||||||||||||
Finished & in-process goods |
33,027 | | | 22,629 | | 55,656 | |||||||||||||||||
Raw materials and supplies |
29,826 | | | 24,942 | | 54,768 | |||||||||||||||||
Other current assets |
18,614 | | 17 | 4,360 | | 22,991 | |||||||||||||||||
260,287 | 15,496 | 8,510 | 252,307 | (54,839 | ) | 481,761 | |||||||||||||||||
Other Assets |
|||||||||||||||||||||||
Investment in subsidiaries |
6,242,903 | | 15,638 | | (6,258,541 | ) | | ||||||||||||||||
Loans receivable from affiliates |
| 482,382 | 6,152,367 | 40,144 | (6,674,893 | ) | | ||||||||||||||||
Other assets |
14,685 | 18,505 | | 20,124 | | 53,314 | |||||||||||||||||
6,257,588 | 500,887 | 6,168,005 | 60,268 | (12,933,434 | ) | 53,314 | |||||||||||||||||
Property and Equipment |
|||||||||||||||||||||||
Land |
24,074 | | | 8,871 | | 32,945 | |||||||||||||||||
Buildings |
65,654 | | | 37,850 | | 103,504 | |||||||||||||||||
Machinery and equipment |
417,776 | | 531 | 314,978 | | 733,285 | |||||||||||||||||
507,504 | | 531 | 361,699 | | 869,734 | ||||||||||||||||||
Less accumulated depreciation |
(266,500 | ) | | (481 | ) | (154,747 | ) | | (421,728 | ) | |||||||||||||
241,004 | | 50 | 206,952 | | 448,006 | ||||||||||||||||||
Goodwill |
34,623 | | | 16,059 | | 50,682 | |||||||||||||||||
Other intangible assets |
4,829 | | | 5,522 | | 10,351 | |||||||||||||||||
Total Assets |
$ | 6,798,331 | $ | 516,383 | $ | 6,176,565 | $ | 541,108 | $ | (12,988,273 | ) | $ | 1,044,114 | ||||||||||
LIABILITIES AND SHAREHOLDERS DEFICIT |
|||||||||||||||||||||||
Current Liabilities |
|||||||||||||||||||||||
Accounts and drafts payable |
$ | 117,978 | $ | | $ | 23 | $ | 104,172 | $ | | $ | 222,173 | |||||||||||
Intercompany accounts payable |
10,274 | 1,727 | 103 | 42,735 | (54,839 | ) | | ||||||||||||||||
Debt payable within one year |
3,588 | | | 8,000 | | 11,588 | |||||||||||||||||
Income taxes payable |
32,398 | | | (842 | ) | | 31,556 | ||||||||||||||||
Interest payable |
12,475 | 13,510 | | 37 | | 26,022 | |||||||||||||||||
Other current liabilities |
53,688 | | 7 | 20,722 | | 74,417 | |||||||||||||||||
230,401 | 15,237 | 133 | 174,824 | (54,839 | ) | 365,756 | |||||||||||||||||
Other Liabilities |
|||||||||||||||||||||||
Long-term debt |
473,582 | 475,000 | | 7,234 | | 955,816 | |||||||||||||||||
Long-term loans payable to affiliates |
6,389,725 | | | 285,168 | (6,674,893 | ) | | ||||||||||||||||
Non-pension postemployment benefit obligations |
113,026 | | | 1,476 | | 114,502 | |||||||||||||||||
Other long-term liabilities |
140,422 | | | 16,443 | | 156,865 | |||||||||||||||||
7,116,755 | 475,000 | | 310,321 | (6,674,893 | ) | 1,227,183 | |||||||||||||||||
Shareholders (Deficit) Equity |
(548,825 | ) | 26,146 | 6,176,432 | 55,963 | (6,258,541 | ) | (548,825 | ) | ||||||||||||||
Total Liabilities & Shareholders (Deficit) Equity |
$ | 6,798,331 | $ | 516,383 | $ | 6,176,565 | $ | 541,108 | $ | (12,988,273 | ) | $ | 1,044,114 | ||||||||||
23
BORDEN CHEMICAL, INC.
Notes to Condensed Consolidated Financial Statements
(Dollars in thousands)
THREE MONTHS ENDED MARCH 31, 2005
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
Borden Chemical, Inc. |
Subsidiary Issuers |
Combined Subsidiary Guanantors |
Combined Non- Guarantor Subsidiaries |
Eliminations |
Consolidated |
|||||||||||||||||||
Cash Flows from (used in) Operating Activities |
||||||||||||||||||||||||
Net (loss) income |
$ | (4,262 | ) | $ | (247 | ) | $ | 62,368 | $ | 7,043 | $ | (69,164 | ) | $ | (4,262 | ) | ||||||||
Adjustments to reconcile net (loss) income to net cash from (used in) operating activities: |
||||||||||||||||||||||||
Non-cash affiliated interest (1) |
52,840 | | (52,840 | ) | | | | |||||||||||||||||
Non-cash allocation of corporate expenses |
(5,271 | ) | | | 5,271 | | | |||||||||||||||||
Equity in earnings of subsidiaries |
(67,126 | ) | | (2,038 | ) | | 69,164 | | ||||||||||||||||
Depreciation and amortization |
7,228 | | 5 | 5,127 | | 12,360 | ||||||||||||||||||
Deferred tax expense (benefit) |
931 | | | (23 | ) | | 908 | |||||||||||||||||
Unrealized loss on derivative instruments |
9,576 | | | 233 | | 9,809 | ||||||||||||||||||
Business realignment and impairments (income) expense |
318 | | | (700 | ) | | (382 | ) | ||||||||||||||||
Gain on sale of venture interest |
| | (1,614 | ) | | | (1,614 | ) | ||||||||||||||||
Other non-cash adjustments |
1,048 | | | (1,058 | ) | | (10 | ) | ||||||||||||||||
Net change in assets & liabilities: |
| |||||||||||||||||||||||
Accounts receivable |
9,055 | | 58 | (790 | ) | | 8,323 | |||||||||||||||||
Inventories |
4,201 | | | 729 | | 4,930 | ||||||||||||||||||
Accounts and drafts payable |
7,505 | (1,100 | ) | (21 | ) | (19,910 | ) | | (13,526 | ) | ||||||||||||||
Income taxes |
(546 | ) | | | 2,672 | | 2,126 | |||||||||||||||||
Other assets |
5,514 | 6,422 | (69 | ) | (5,258 | ) | | 6,609 | ||||||||||||||||
Other liabilities |
(13,856 | ) | (6,443 | ) | (5 | ) | 7,205 | | (13,099 | ) | ||||||||||||||
7,155 | (1,368 | ) | 5,844 | 541 | | 12,172 | ||||||||||||||||||
Cash Flows (used in) from Investing Activities |
||||||||||||||||||||||||
Capital expenditures |
(4,659 | ) | | | (1,822 | ) | | (6,481 | ) | |||||||||||||||
Deferred acquisition costs |
(9,128 | ) | | | | | (9,128 | ) | ||||||||||||||||
Proceeds from sale of venture interest |
| | 2,507 | | | 2,507 | ||||||||||||||||||
(13,787 | ) | | 2,507 | (1,822 | ) | | (13,102 | ) | ||||||||||||||||
Cash flows (used in) from Financing Activities |
||||||||||||||||||||||||
Net short-term debt repayments |
(1,794 | ) | | | (1,613 | ) | | (3,407 | ) | |||||||||||||||
Repayments of long-term debt |
| | | (663 | ) | | (663 | ) | ||||||||||||||||
Affiliated loan (repayments) borrowings |
6,394 | 1,412 | (6,000 | ) | (1,806 | ) | | | ||||||||||||||||
Purchase price adjustment payable to parent |
7,500 | | | | | 7,500 | ||||||||||||||||||
Dividends received (paid) |
3,987 | | (2,507 | ) | (1,480 | ) | | | ||||||||||||||||
16,087 | 1,412 | (8,507 | ) | (5,562 | ) | | 3,430 | |||||||||||||||||
Effect of exchange rates on cash |
| | | (303 | ) | | (303 | ) | ||||||||||||||||
Increase (decrease) in cash and equivalents |
9,455 | 44 | (156 | ) | (7,146 | ) | | 2,197 | ||||||||||||||||
Cash & equivalents beginning of period |
55,199 | 2 | 600 | 66,310 | | 122,111 | ||||||||||||||||||
Cash & equivalents at end of period |
$ | 64,654 | $ | 46 | $ | 444 | $ | 59,164 | $ | | $ | 124,308 | ||||||||||||
(1) | Interest on affiliated debt to certain guarantor subsidiaries is settled by increasing the loan principal. |
24
BORDEN CHEMICAL, INC.
Notes to Condensed Consolidated Financial Statements
(Dollars in thousands)
THREE MONTHS ENDED MARCH 31, 2004
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
Borden Chemical, Inc. |
Subsidiary Issuers |
Combined Subsidiary Guarantors |
Combined Non- Guarantor Subsidiaries |
Eliminations |
Consolidated |
||||||||||||||||||
Cash Flows from (used in) Operating Activities |
|||||||||||||||||||||||
Net income |
$ | 4,914 | $ | | $ | 32,202 | $ | 4,866 | $ | (37,068 | ) | $ | 4,914 | ||||||||||
Adjustments to reconcile net income to net cash from (used in) operating activities: |
|||||||||||||||||||||||
Non-cash affiliated interest (1) |
26,235 | | (26,235 | ) | | | | ||||||||||||||||
Equity in earnings of subsidiaries |
(35,787 | ) | | (1,281 | ) | | 37,068 | | |||||||||||||||
Non-cash allocation of corporate expenses |
(3,801 | ) | | | 3,801 | | | ||||||||||||||||
Depreciation and amortization |
7,299 | | 31 | 4,613 | | 11,943 | |||||||||||||||||
Deferred tax expense (benefit) |
(1,427 | ) | | | 65 | | (1,362 | ) | |||||||||||||||
Business realignment expense and impairments |
441 | | | 1,053 | | 1,494 | |||||||||||||||||
Unrealized gain on derivative instruments |
(145 | ) | | | | | (145 | ) | |||||||||||||||
Other non-cash adjustments |
986 | | | (5 | ) | | 981 | ||||||||||||||||
Net change in assets and liabilities: |
| ||||||||||||||||||||||
Accounts receivable |
(5,025 | ) | | 8 | 1,404 | | (3,613 | ) | |||||||||||||||
Inventories |
5,131 | | | (2,893 | ) | | 2,238 | ||||||||||||||||
Accounts and drafts payable |
8,143 | | (13 | ) | 7,856 | | 15,986 | ||||||||||||||||
Income taxes |
520 | | | (1,545 | ) | | (1,025 | ) | |||||||||||||||
Other assets |
581 | | 43 | (8,658 | ) | | (8,034 | ) | |||||||||||||||
Other liabilities |
(15,932 | ) | | (13 | ) | (1,601 | ) | | (17,546 | ) | |||||||||||||
(7,867 | ) | | 4,742 | 8,956 | | 5,831 | |||||||||||||||||
Cash Flows from (used in) Investing Activities |
|||||||||||||||||||||||
Capital expenditures |
(3,336 | ) | | | (4,135 | ) | | (7,471 | ) | ||||||||||||||
Proceeds from the sale of assets |
| | | 8,105 | | 8,105 | |||||||||||||||||
(3,336 | ) | | | 3,970 | | 634 | |||||||||||||||||
Cash flows (used in) from Financing Activities |
|||||||||||||||||||||||
Net short-term debt repayments |
(1,529 | ) | | | (1,497 | ) | | (3,026 | ) | ||||||||||||||
Borrowings of long-term debt |
| | | 3,028 | | 3,028 | |||||||||||||||||
Affiliated loan (repayments) borrowings |
(2,143 | ) | | 10,000 | (12,817 | ) | | (4,960 | ) | ||||||||||||||
Dividends received (paid) |
14,600 | | (14,600 | ) | | | | ||||||||||||||||
10,928 | | (4,600 | ) | (11,286 | ) | | (4,958 | ) | |||||||||||||||
Effect of exchange rates on cash |
| | | (37 | ) | | (37 | ) | |||||||||||||||
Increase (decrease) in cash and equivalents |
(275 | ) | | 142 | 1,603 | | 1,470 | ||||||||||||||||
Cash and equivalents beginning of period |
1,370 | | 151 | 26,641 | | 28,162 | |||||||||||||||||
Cash and equivalents at end of period |
$ | 1,095 | $ | | $ | 293 | $ | 28,244 | $ | | $ | 29,632 | |||||||||||
(1) | Interest on affiliated debt to certain guarantor subsidiaries is settled by increasing the loan principal |
25
12. Subsequent Events
Bakelite Acquisition
On April 29, 2005, Borden Chemical Canada, Inc., a subsidiary of the Company, through its wholly owned subsidiary, National Borden Chemical Germany Gmbh, completed its acquisition of Bakelite Aktiengesellschaft (Bakelite) pursuant to a share purchase agreement with RUTGERS AG and RUTGERS Bakelite Projekt GmbH (collectively, the Sellers) dated October 6, 2004. Based in Iserlohn-Letmathe, Germany, Bakelite is a leading source of phenolic and epoxy thermosetting resins and molding compounds with 13 manufacturing facilities and 1,700 employees in Europe and Asia.
In the transaction, the Sellers exchanged all of their respective shares of Bakelites stock for cash and debt assumed in an aggregate amount of EUROS 207,000, or approximately $267,000. The transaction was financed via a second-priority senior secured bridge loan facility in the amount of $250,000 and available cash. The bridge financing arrangement has a variable interest rate equal to LIBOR plus an applicable margin and has a final maturity date of July 15, 2014. The acquisition will be accounted for under the purchase method of accounting.
Hexion Combination
As of April 22, 2005, the Company entered into a merger agreement with Resolution Performance Products, Inc. (RPP) and Resolution Specialty Materials, Inc. (RSM) (the Merger). The Company, RPP and RSM are controlled by Apollo. The Merger is expected to close during the second quarter of 2005. Upon the consummation of the Merger, the Company will change its name to Hexion Specialty Chemicals, Inc. (Hexion). Completion of the Merger is subject to customary closing conditions and the Company, RPP and RSM will continue to operate independently until those conditions are satisfied and each of the closings occur. The Merger will be treated, for accounting purposes, as a combination of entities under common control.
Hexion Preferred Stock
In May 2005, Hexion Escrow Corp., which will be merged with Hexion upon consummation of the Merger, offered 14 million shares of Series A Floating Rate Preferred Stock (the Preferred Stock), par value $0.01 per share, and initial liquidation preference of $25 per share. The Preferred Stock will accumulate cumulative preferential dividends from the issue date at an initial rate of LIBOR plus 8.0%, compounded semi-annually. Prior to November 2005, the Company has the option to redeem all or a portion of the Preferred Stock at 100% of the aggregate liquidation value plus accrued and unpaid dividends. The Company expects to use the proceeds from its initial public offering, discussed below, to redeem the Preferred Stock. If the Merger is not consummated by July 31, 2005, the Preferred Stock is subject to special mandatory redemption. The net proceeds from the Preferred Stock issuance are expected to be $336,000, after deducting underwriting expenses and estimated expenses of the offering, and will be used to pay a dividend to the Companys parent.
Registration Statement
On April 25, 2005, the Company filed a registration statement, which is not yet effective, with the U.S. Securities and Exchange Commission (the SEC) for a proposed initial public offering of its common stock. The Company intends to commence the sale of its common stock to the public, after completion of the Merger and upon approval by the SEC of the registration statement, under the Hexion Specialty Chemicals, Inc. name. The Company and a selling shareholder will sell the shares of common stock. The Company will not receive any of the proceeds from the sale of shares by the selling shareholder. The proceeds from the sale of shares by the Company will be used to redeem the Hexion Preferred Stock discussed above.
26
Item 2: Managements Discussion and Analysis of Financial Condition and Results of Operations (amounts in thousands)
Forward-Looking and Cautionary Statements
As management of Borden Chemical, Inc. (which made be referred to as Borden, BCI, we, us, our or the Company) we may, from time to time, make written and oral statements regarding the future performance of the Company, including statements contained in this report and our other reports filed with the Securities and Exchange Commission. Investors should be aware that these statements, which may include words such as believe, expect, anticipate, estimate or intend, are based on our currently available financial, economic and competitive data and on current business plans. Such risks and uncertainties are primarily in the areas of results of operations by business unit, liquidity, legal and environmental liabilities and industry and economic conditions.
Apollo Transaction
In the third quarter of 2004, BCI was acquired by an affiliate of Apollo Management, L.P. (Apollo). Our immediate parent is BHI Acquisition Corp. (BHI Acquisition), which is a wholly owned subsidiary of BHI Investment LLC, an entity controlled by Apollo. The transactions related to the acquisition of the Company by Apollo are referred to collectively as the Apollo Transaction.
Overview
We are a leading global integrated producer of thermoset-based resins and adhesives for the global forest products and industrial markets. In addition, we are the worlds largest producer by volume of formaldehyde, an important and versatile building block chemical used in a variety of applications. We are the largest North American producer by volume of thermoset-based resins used in the production of engineered wood products, including structural wood panels, beams and non-structural panels, furniture, door and window assemblies and wallboards. We are also the largest North American producer by volume of resin-coated proppant systems, which are used in oilfield and natural gas production, and of foundry resins, which are used in the production of cores and molds for metal castings. We have a strong presence in the production of specialty resins used in the industrial, automotive and electronics markets.
Our three reporting segments are the following: Forest Products, Performance Resins and International. Our results also include general corporate and administrative expenses disclosed as Corporate and Other, presented to provide a complete picture of our results.
Forest Products includes the forest product resins and formaldehyde product lines produced in North America. The key business drivers for Forest Products are housing starts, furniture demand, panel production capacity and chemical intermediates sector operating conditions.
Performance Resins includes the specialty resins, foundry resins and oilfield product lines produced in North America. Performance Resins key business drivers are housing starts, auto builds, active gas drilling rigs and the general industrial sector performance.
International includes production operations in Europe, Latin America and Asia Pacific. Principal countries of operation are the U.K., Brazil, Australia and Malaysia. Product lines include formaldehyde, forest product and performance resins and consumer products. The key business drivers for International are export levels, panel production capacity, housing starts, furniture demand and the local political and general economic environments.
Corporate and Other represents general and administrative expenses and income and expenses related to liabilities retained from businesses sold in previous years.
As of April 22, 2005, we entered into a merger agreement with Resolution Performance Products, Inc., or RPP, and Resolution Specialty Materials, Inc., or RSM. The Company, RPP and RSM are controlled by Apollo. The merger is expected to close during the second quarter of 2005. Upon the consummation of the merger, we will change our name to Hexion Specialty Chemicals, Inc., which we refer to as Hexion. Completion of the merger is subject to customary closing conditions and the Company, RPP and RSM will continue to operate independently until those conditions are satisfied and each of the closings occur. The merger will be treated, for accounting purposes, as a combination of entities under common control. Collectively, we refer to this merger as the Hexion Combination.
27
On April 25, 2005, the Company filed a registration statement, which is not yet effective, with the U.S. Securities and Exchange Commission (SEC), for a proposed initial public offering of its common stock. The Company intends to commence the sale of its common stock to the public, after completion of the merger and upon approval by the SEC of the registration statement, under the Hexion Specialty Chemicals, Inc. name.
On April 29, 2005, through our wholly owned subsidiary, National Borden Chemical Germany Gmbh, we completed our acquisition of Bakelite Aktiengesellschaft, or Bakelite, pursuant to our share purchase agreement with RUTGERS AG and RUTGERS Bakelite Projekt GmbH dated October 6, 2004. Based in Iserlohn-Letmathe, Germany, Bakelite is a leading source of phenolic and epoxy thermosetting resins and molding compounds with 13 manufacturing facilities and 1,700 employees in Europe and Asia.
Overview of Results
Our net sales increased $99,732, or 25.9%, in the first quarter of 2005 versus the first quarter of 2004. Net sales benefited from strong pricing and improved product mix. Our strong pricing is due to the pass through of raw material cost increases in all three reporting segments, and we experienced improved product mix primarily in our nonwoven resins and oilfield products. Improved volumes, primarily in formaldehyde, forest products and foundry resins, oilfield products and Europe, also contributed to the increase. Favorable currency translation, in all countries in which we operate, also positively impacted net sales.
We reported a net loss of $4,262 for the first quarter of 2005 versus net income of $4,914 for the first quarter of 2004. The $9,176 reduction in net income was primarily due to an increase in interest expense of $9,895, which relates to our issuance of the $475 million of Second Priority Notes in August of 2004 as part of the Apollo Transaction, an increase in other non-operating expense of $8,907, primarily relating to a loss on the mark to market of a deal contingent forward related to the Bakelite Acquisition (see Note 6 to the Condensed Consolidated Financial Statements) and an increase in income tax expense of $1,396. Offsetting these increased expenses was an increase in operating income of $12,667. The increase in operating income was primarily driven by increased volumes, higher average selling prices and lower business realignment expenses.
Critical Accounting Policies
For a discussion of our critical accounting policies, refer to Managements Discussion and Analysis of Financial Condition and Results of Operations in Item 7 on page 17 and in Note 2 to the Consolidated Financial Statements on page 43 of the Companys Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 28, 2005. Our critical accounting policies did not change during the first quarter of 2005.
Results of Operations by Segment:
Following is a comparison of net sales and Segment EBITDA. Segment EBITDA is equal to income (loss) before depreciation and amortization, interest expense, other non-operating expenses or income, income taxes and other adjustments (which include costs included in operating income associated with the Apollo Transaction, business realignment activities, certain costs primarily related to legacy businesses, dispositions and pension settlement charges, if any). Segment EBITDA is presented by reportable segment and for Corporate and Other of the Company for the three months ended March 31, 2005 and 2004. Segment EBITDA information is presented with the Companys segment disclosures because it is the measure used by the Companys management in the evaluation of operating results and in determining allocations of capital resources among the business segments. It is also the metric used by the Company to set management and executive incentive compensation.
28
Net Sales | ||||||
2005 |
2004 | |||||
Forest Products |
$ | 256,082 | $ | 194,667 | ||
Performance Resins |
123,054 | 101,964 | ||||
International |
106,030 | 88,803 | ||||
$ | 485,166 | $ | 385,434 | |||
Segment EBITDA | ||||||||
2005 |
2004 |
|||||||
Forest Products |
$ | 28,399 | $ | 23,721 | ||||
Performance Resins |
15,382 | 11,019 | ||||||
International |
10,648 | 9,029 | ||||||
Corporate and Other |
(10,167 | ) | (8,922 | ) | ||||
$ | 44,262 | $ | 34,847 | |||||
Reconciliation of Segment EBITDA to Net (Loss) Income | ||||||||
Three Months ended March 31, |
||||||||
2005 |
2004 |
|||||||
Segment EBITDA |
$ | 44,262 | $ | 34,847 | ||||
Depreciation and amortization |
(12,360 | ) | (11,943 | ) | ||||
Adjustments to Segment EBITDA (see page 30) |
67 | (2,102 | ) | |||||
Interest expense |
(21,785 | ) | (11,890 | ) | ||||
Other non-operating expense |
(9,113 | ) | (61 | ) | ||||
Income tax expense |
(5,333 | ) | (3,937 | ) | ||||
Net (loss) income |
$ | (4,262 | ) | $ | 4,914 | |||
THREE MONTHS ENDED MARCH 31, 2005 VERSUS THREE MONTHS ENDED MARCH 31, 2004
Net Sales Variance |
2005 As a Percentage Increase from 2004 |
|||||||||||
Volume |
Price/Mix |
Translation |
Total |
|||||||||
Forest Products |
4.4 | % | 24.1 | % | 3.0 | % | 31.5 | % | ||||
Performance Resins |
5.9 | % | 14.7 | % | 0.1 | % | 20.7 | % | ||||
International |
2.5 | % | 11.0 | % | 5.9 | % | 19.4 | % |
Forest Products
Forest Products first quarter net sales of $256,082 increased $61,415, or 31.5%, compared to 2004. Favorable pricing and mix and improved volumes primarily drove the increase in sales. Strong pricing for our phenolic-based, or PF, resins and our urea-based, or UF, resins was primarily due to the pass through of raw material price increases. We experienced improved volumes primarily for our formaldehyde, PF resins and UF resins. The improved formaldehyde volumes were primarily due to broad-based demand in the general chemical sector, while our improved PF and UF resins volumes related to the continued strong housing market. Sales also benefited from favorable currency translation as the Canadian dollar strengthened versus the U.S. dollar.
Forest Products Segment EBITDA for the first quarter of 2005 of $28,399 was an increase of $4,678, or 19.7%, over prior year. The improvement in Segment EBITDA was primarily due to improved margins despite continuing high methanol and phenol prices. Our margin improvement is attributed to purchasing productivity and our ability to pass along raw material price increases. Higher volumes and favorable currency translation also contributed to the improvement.
29
Performance Resins
Performance Resins first quarter net sales of $123,054 were an increase of $21,090, or 20.7%, over the comparable period of the prior year. Increased selling prices and improved volumes were the drivers of the increase. Selling prices increased for our industrial and foundry resins, and we experienced favorable product mix for our nonwoven resins and oilfield products. Improved volumes for our foundry resins and oilfield products were partially offset by reduced volumes for our electronics products. The increase in foundry resins volumes was due to strong demand in the non-automotive casting segments. Strong drilling activity in East Texas, the Rockies and the Mid-Continent region drove the volume increase in oilfield products. The decline in electronics volumes was primarily due to the timing of and change in customer demand.
First quarter Segment EBITDA for Performance Resins of $15,382 increased $4,363, or 39.6%, compared to the comparable period of 2004. Volume increases primarily in foundry resins and oilfield products were a main driver of the improvement in Segment EBITDA. Also contributing to the increase was favorable product mix in our industrial resins and reduced processing costs. Offsetting these improvements was increased freight costs across most of our products due to a shift to more prepaid freight deliveries.
International
First quarter 2005 International sales of $106,030 were an increase of $17,227, or 19.4%, over the first quarter of 2004. Strong pricing, favorable currency translation and improved volumes all contributed to the increase in sales. Strong pricing across all international regions was due to the pass through of higher raw material costs. We experienced favorable currency translation across all international regions as well. Improved European volumes, primarily in Industrial Resins due to the addition of new customers, were partially offset by reduced volumes in Latin America, primarily related to decreased demand for forest product resins in the region. The decrease in demand is due to reduced plywood exports to Europe and the U.S. as a result of market conditions and a less competitive exchange rate.
International Segment EBITDA of $10,648 increased $1,619, or 17.9%, in first quarter 2005 compared to the same period of 2004. Reduced processing costs, improved European volumes and favorable currency translation across all international regions drove the improvement in Segment EBITDA. These improvements were partially offset by reduced margins due to competitive pricing pressures in Europe and Asia Pacific and increased freight costs in Europe and Latin America.
Corporate and Other
Our first quarter 2005 Corporate and Other expenses increased $1,245 compared to our first quarter 2004 expenses. The increase is primarily due to adjustments made to our legal, environmental and general insurance reserves.
Adjustments to Segment EBITDA
We rely primarily on Segment EBITDA in the evaluation of operating results and the allocation of capital resources. The following tables detail items not included in Segment EBITDA for purposes of this evaluation of our operating segments. We monitor these activities separately from our operating results. These (expense) income items primarily relate to our realignment programs and asset impairments:
Three months ended March 31, 2005 |
Plant Closure |
Severance |
Other |
Total |
||||||||||||
Forest Products |
$ | (196 | ) | $ | | $ | | $ | (196 | ) | ||||||
Performance Resins |
(215 | ) | | 1,614 | 1,399 | |||||||||||
International |
(116 | ) | | 1,005 | 889 | |||||||||||
Corporate and Other |
| (96 | ) | (1,929 | ) | (2,025 | ) | |||||||||
$ | (527 | ) | $ | (96 | ) | $ | 690 | $ | 67 | |||||||
Plant closure costs in the first quarter of 2005 of $527 related to costs associated with a plant closing due to changes in the Companys manufacturing footprint of $216, the transition of manufacturing from the Companys North Bay, Ontario plant to another facility of $152, environmental remediation of $71 for closed plants in Brazil and other plant closure costs of $88.
30
We recorded severance costs of $96 related primarily to the 2003 realignment program.
Other income of $690, not included in first quarter 2004 Adjusted EBITDA, primarily represents the gain recognized on the sale of an additional 5% interest in HA International, our venture interest that we call HAI, and a gain on the sale of assets impaired in 2004. See Notes 3 and 4 to the Condensed Consolidated Financial Statements. These amounts were partially offset by transaction costs associated with the Hexion Combination. See Note 1 to the Condensed Consolidated Financial Statements.
Three months ended March 31, 2004 |
Plant Closure |
Severance |
Other |
Total |
||||||||||||
Forest Products |
$ | (22 | ) | $ | (274 | ) | $ | (39 | ) | $ | (335 | ) | ||||
International |
(748 | ) | (153 | ) | | (901 | ) | |||||||||
Corporate and Other |
13 | (310 | ) | (569 | ) | (866 | ) | |||||||||
$ | (757 | ) | $ | (737 | ) | $ | (608 | ) | $ | (2,102 | ) | |||||
Plant closure costs in the first quarter of 2004 of $757 related to the conversion of our French manufacturing facility into a distribution center and the transition of the related production to the U.K. ($244), environmental remediation at closed plants in Brazil ($238) and other plant closure costs at various sites ($275).
We recorded severance costs of $737 related primarily to the 2003 realignment program.
Other expenses of $608 not included in first quarter 2004 Adjusted EBITDA primarily represent severance expense, included in general and administrative expense, for positions to be replaced as part of the 2003 realignment program.
Non-operating Expenses and Income Taxes
Following is a comparison of our non-operating expenses for the three months ended March 31, 2005 and 2004:
Three months ended March 31, | ||||||
2005 |
2004 | |||||
Interest expense |
$ | 21,785 | $ | 11,890 | ||
Other non-operating expense |
9,113 | 61 | ||||
$ | 30,898 | $ | 11,951 | |||
Our total non-operating expenses increased $18,947 in the first quarter of 2005 as compared to the first quarter of 2004. Interest expense increased $9,895 over 2004 due to higher average debt balances resulting from our issuance of the $450 million of Second Priority Notes in August of 2004 as part of the Apollo Transaction. Included in other non-operating expense in 2005 was a $10,432 unrealized loss on the mark to market of a deal contingent forward held by us relating to the pending Bakelite acquisition. See Note 6 to the Condensed Consolidated Financial Statements.
Following is a comparison of income tax expense related to continuing operations for the three months ended March 31, 2005 and 2004:
Three months ended March 31, |
|||||||
2005 |
2004 |
||||||
Income tax expense |
$ | 5,333 | $ | 3,937 | |||
Effective tax rate |
N/M | 44 | % |
The 2005 income tax expense primarily reflects income taxes on earnings in international jurisdictions, as well as withholding taxes related to the unremitted earnings of foreign subsidiaries.
The 2004 effective tax rate reflects the effect of certain foreign losses that we cannot utilize to offset current or future taxable income. Consequently, no tax benefit has been recorded to recognize a current or future benefit of those foreign losses. Additionally, the effective rate reflects higher effective tax rates in certain international jurisdictions.
31
Cash Flows:
Cash provided by (used in):
Three months ended March 31, |
||||||||
2005 |
2004 |
|||||||
Operating activities |
$ | 12,172 | $ | 5,831 | ||||
Investing activities |
(13,102 | ) | 634 | |||||
Financing activities |
3,430 | (4,958 | ) | |||||
Effect of exchange rates on cash flow |
(303 | ) | (37 | ) | ||||
Net change in cash and cash equivalents |
$ | 2,197 | $ | 1,470 | ||||
Operating Activities
Our first quarter 2005 operating activities provided cash of $12,172. Cash generated from earnings after adjusting for non-cash expenses of approximately $16,800 and collections of miscellaneous receivables primarily related to rebates of approximately $25,000 were the primary sources of cash from operating activities. This generation of cash was substantially offset by net trading capital outflows of approximately $16,300 and interest payments of approximately $31,497.
Our first quarter 2004 operating activities provided cash of $5,831. Cash generated from earnings after adjusting for non-cash expenses of approximately $17,800 and collections of receivables primarily related to rebates of approximately $8,900 were the primary sources of cash from operating activities. This generation of cash was substantially offset by net interest and tax payments of about $22,400 and net trading capital outflows of approximately $2,600.
Investing Activities
Our investing activities used cash of $13,102 in the first quarter of 2005. We used $6,481 for capital expenditures, primarily for plant expansions and improvements. In addition, we used $9,128 for deferred acquisition costs associated with the Bakelite acquisition. See Note 1 to the Condensed Consolidated Financial Statements. We received proceeds of $2,507 on our sale of an additional 5% interest in HAI. See Note 3 to the Condensed Consolidated Financial Statements.
Our investing activities in the first quarter of 2004 provided cash of $634. We received proceeds of $8,105, primarily from collection on a receivable from the 2003 sale of land associated with a closed plant in the U.K. We used $7,471 for capital expenditures, primarily for plant expansions and improvements.
Financing Activities
Our financing activities provided cash of $3,430 in the first quarter of 2005. The receipt of a $7,500 purchase price adjustment related to the Apollo Transaction was partially offset by repayments on our short and long-term debt.
Our financing activities used cash of $4,958 in the first quarter of 2004. We used this cash primarily to make repayments on our affiliated borrowings.
Liquidity and Capital Resources
Our primary source of liquidity is cash flow generated from operations. We also have availability under our asset-based revolving line of credit in our senior secured credit facility, which we refer to as our Credit Facility, subject to certain conditions. Our primary liquidity requirements are for debt service, working capital requirements, contractual obligations and capital expenditures.
We are a highly leveraged company. Our liquidity requirements are significant, primarily due to our debt service requirements. At March 31, 2005, we had $963,338 principal amount of outstanding indebtedness, of which $150,000 constituted floating rate notes and $813,338 constituted fixed rate indebtedness. We had no amounts borrowed under our Credit Facility at March 31, 2005.
32
We entered into a three-year asset based revolving Credit Facility in the third quarter of 2002, under which we can borrow in aggregate up to $175,000. We amended this Credit Facility, which we refer to as our Amended Credit Facility, on August 12, 2004 as part of the Apollo Transaction. The Amended Credit Facility provides for loans and letters of credit in a total principal amount of up to $175,000 and expires in 2009. The Amended Credit Facility includes a $57,000 revolving credit subfacility for our Canadian subsidiary, a $30,000 revolving credit subfacility for our U.K. subsidiary and a letter of credit subfacility of at least $100,000.
Our Amended Credit Facility is secured with inventory and accounts receivable in the U.S., Canada and the U.K., a portion of property and equipment in Canada and the U.K. and the stock of certain subsidiaries. The maximum borrowing allowable under our Amended Credit Facility is calculated monthly (quarterly, if availability is greater than $100,000) and is based upon specific percentages of eligible accounts receivable, inventory, fixed assets and cash. This Amended Credit Facility contains restrictions on dividends, capital expenditures ($75,000 in 2005) and payment of management fees ($3,000 per year or 2% of EBITDA, as defined in the agreement). It also includes a minimum trailing twelve-month fixed charge coverage ratio of 1.1 to 1.0, if aggregate availability is less than $50,000. The trailing twelve-month fixed charge coverage ratio requirement does not apply when aggregate availability exceeds $50,000. At March 31, 2005, our maximum borrowing allowable under the Amended Credit Facility was approximately $175,000 of which about $125,500, after outstanding LOCs and other draws, was unused and available. As a result, we have no fixed charge coverage ratio requirements at March 31, 2005.
HAI entered into a three-year asset backed revolving credit facility on January 28, 2004, which provides for a maximum borrowing of $15,000, as amended on October 29, 2004 (the HAI Facility). Maximum borrowing allowable under the HAI Facility is based upon specific percentages of eligible accounts receivable and inventory and is secured with inventory, accounts receivable and property and equipment of HAI. The HAI Facility contains restrictions relative to HAI on dividends, affiliate transactions, minimum availability ($2,000), additional debt and capital expenditures ($2,000 in 2005). In addition, HAI is required to maintain a minimum trailing twelve-month debt coverage ratio of 1.5 to 1.0 and a monthly debt to tangible capital ratio of less than 2.5 to 1.0. At March 31, 2005, borrowing allowable under the HAI Facility was approximately $14,500, of which approximately $12,500 was unused and available, after the minimum availability requirement.
Our Australian subsidiary entered into a five-year secured credit facility in the fourth quarter of 2003 (the Australian Facility), which provides for a maximum borrowing of AUD$19,900, or approximately $15,400. The Australian Facility is secured by liens against substantially all of the assets of the Australian business including the stock of Australian subsidiaries. In addition, the stock of Australia is pledged as collateral for borrowings under the Australian Facility. This facility includes a fixed rate component used for the acquisition, as well as a revolver and LOC facility. This facility restricts the Australian subsidiaries on the payment of dividends, the sale of assets and additional borrowings by the Australian businesses outside of this facility. This facility also contains financial covenants applying to the Australian subsidiaries including current ratio, interest coverage, debt service coverage and leverage. At March 31, 2005, the maximum borrowing allowable under the Australian Facility was AUD$16,900 (approximately $13,100), of which about AUD$2,900 (approximately $2,200), after outstanding LOCs and other draws, was unused and available.
As discussed in Note 12 to the Condensed Consolidated Financial Statements, on April 29, 2005, Borden Chemical Canada, Inc., a subsidiary of the Company, through its wholly owned subsidiary, National Borden Chemical Germany Gmbh, completed its acquisition of Bakelite Aktiengesellschaft (Bakelite) pursuant to a share purchase agreement with RUTGERS AG and RUTGERS Bakelite Projekt GmbH (collectively, the Sellers) dated October 6, 2004. In the transaction, the Sellers exchanged all of their respective shares of Bakelites stock for cash in an aggregate amount of EUROS 207,000, or approximately $267,000. The transaction was financed via a second-priority senior secured bridge loan facility in the amount of $250,000 and available cash. The bridge financing arrangement has a variable interest rate equal to LIBOR plus an applicable margin and has a final maturity date of July 15, 2014.
Previous buybacks of our senior unsecured notes allow us to fulfill our sinking fund requirements through 2013 for our 8.375% debentures. In the future, we, or our affiliates, including entities controlled by Apollo, may purchase our senior unsecured notes in the open market or by other means, depending on market conditions.
We expect to have adequate liquidity to fund working capital requirements, contractual obligations and capital expenditures over the remainder of the five-year term of our Amended Credit Facility with cash received from operations, amounts available under the Amended Credit Facility and amounts available under our subsidiaries separate credit facilities.
33
In May 2005, in connection with the Hexion Combination, Hexion Escrow Corp., which will be merged with the Company upon consummation of the Hexion Combination, offered 14 million shares of Series A Floating Rate Preferred Stock, which we refer to as the Preferred Stock, par value $0.01 per share, and initial liquidation preference of $25 per share. The Preferred Stock will accumulate cumulative preferential dividends from the issue date at an initial rate of LIBOR plus 8.0%, compounded semi-annually. Prior to November 2005, the Company has the option to redeem all or a portion of the Preferred Stock at 100% of the aggregate liquidation value plus accrued and unpaid dividends. The Company expects to use the proceeds from its initial public offering, discussed in the Overview section above, to redeem the Preferred Stock. If the Hexion Combination is not consummated by July 31, 2005, the Preferred Stock is subject to special mandatory redemption. The net proceeds from the Preferred Stock issuance are expected to be $336,000, after deducting underwriting expenses and estimated expenses of the offering, and will be used to pay a dividend to the Companys parent.
Upon consummation of the Hexion Combination, we will also enter into $775 million of new senior secured credit facilities. We will use proceeds from a portion of the borrowings under our new senior secured credit facilities, together with the proceeds of this Series A Preferred Stock offering, to pay a special dividend of approximately $550 million to our common stockholders. In addition, in connection with the Bakelite Acquisition we have borrowed $250 million under our bridge loan facility, which we expect to repay in full with the issuance of additional senior secured debt and available cash.
Capital Expenditures
As a combined entity, Hexion plans to spend approximately $120 on capital expenditures in 2005 and approximately $110 annually thereafter. Of the $110 anticipated future capital expenditures, we expect approximately $65 will be used for maintenance projects and approximately $45 for plans to continue increasing plant production capacity as necessary to meet demand and ROI projects. We plan to fund capital expenditures through operations and, if necessary, through available lines of credit.
Off-Balance Sheet Arrangements
We have no off-balance sheet arrangements.
Covenant Compliance
Adjusted EBITDA is used to determine compliance with the debt incurrence covenant contained in the indenture governing the Floating and Fixed Rate Notes. Because we are highly leveraged, our compliance with this covenant is important for the investors in the Companys debt.
Adjusted EBITDA is defined as Net income adjusted to exclude depreciation and amortization, interest expense, non-operating income and expenses, unusual items and certain pro forma adjustments permitted in calculating covenant compliance under the indentures governing the notes and our Amended Credit Facility. We believe that the inclusion of supplemental adjustments to net income applied in presenting Adjusted EBITDA are appropriate to provide additional information to investors to demonstrate compliance with our financing covenants.
During the first quarter, we received a waiver of the dividend restriction under the HAI Facility for a dividend declared in the first quarter. As of March 31, 2005, we were in compliance with all material covenants contained in our indenture governing the notes and credit facilities.
34
Reconciliation of Adjusted EBITDA to Net (Loss) Income
Three months ended March 31, | |||||||
2005 |
2004 | ||||||
Net (loss) income |
$ | (4,262 | ) | $ | 4,914 | ||
Depreciation and amortization |
12,360 | 11,943 | |||||
Adjustments to Segment EBITDA (see page 30) |
(67 | ) | 2,102 | ||||
Interest expense |
21,785 | 11,890 | |||||
Other non-operating expense |
9,113 | 61 | |||||
Income tax expense |
5,333 | 3,937 | |||||
Segment EBITDA |
44,262 | 34,847 | |||||
Adjusted EBITDA (a) (c): |
|||||||
Management fees |
625 | 837 | |||||
Brazil reactor impact (b) |
(500 | ) | | ||||
Cost savings |
156 | 1,310 | |||||
Benefit plan subsidy amendment |
| 375 | |||||
Purchasing power savings |
| 1,625 | |||||
Adjusted EBITDA |
$ | 44,543 | $ | 38,994 | |||
(a) | To arrive at Adjusted EBITDA, we are required to make adjustments to net income for management fees paid to our sponsors, unusual operating impacts and certain pro forma adjustments. These pro forma adjustments include the full year impact of completed acquisitions and approved amendments to our postretirement plan and cost and purchasing savings we expect to achieve. |
(b) | Amount represents the impact of the mechanical failure of a Brazilian reactor that occurred in the third quarter of 2004. The Company filed an insurance claim to recover substantially all losses related to this item and received an installment payment of $500 in the first quarter of 2005. In April 2005, the Company received the remaining $2,750 payable under the insurance claim. |
(c) | To incur additional debt under the Floating and Fixed Note indenture, a Fixed Charge Coverage Ratio of greater than 2 to 1 must be maintained. The Companys ratio as of March 31, 2005 after giving effect to the acquisition and additional debt was 3.0 to 1. |
Recent Accounting Pronouncements
None.
35
ITEM 3: Quantitative and Qualitative Disclosures about Market Risk
There have been no material changes to the information on market risk reported in the Companys Annual Report on Form 10-K at December 31, 2004.
ITEM 4: Controls and Procedures
(a) | Evaluation of Disclosures Controls and Procedures: As of the end of the period covered by this Quarterly Report on Form 10-Q, we carried out an evaluation, under the supervision and with the participation of our Disclosure Committee and our management, including our President and Chief Executive Officer and our Executive Vice President and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures pursuant to Exchange Act Rules 13a-15(e) and 15d-15(e). Based on that evaluation, the President and Chief Executive Officer and Executive Vice President and Chief Financial Officer concluded that our disclosure controls and procedures were effective to ensure that information we are required to disclose in reports that we file or submit under the Exchange Act are recorded, processed, summarized and reported within the time periods specified in the SECs rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. |
(b) | Changes in Internal Controls: As a result of deficiencies identified by management in the income tax reporting process, the Company has engaged an international accounting firm to provide tax accounting and compliance services and to support current tax personnel. No other changes occurred in the Companys internal control over financial reporting during the Companys most recent fiscal quarter that materially affected, or is reasonably likely to materially affect, the Companys internal control over financial reporting. |
The Fayetteville, NC facility is negotiating a settlement with the North Carolina Department of Revenue and Natural Resources relating to alleged non-compliance with permitting requirements and air emission standards at that facility. At this time, we cannot be certain that the monetary sanctions associated with these allegations will not exceed $100,000.
Item 2: Unregistered Sales of Equity Securities and Use of Proceeds
There were no changes in securities during the first quarter of 2005.
Item 3: Defaults upon Senior Securities
There were no defaults on senior securities during the first quarter of 2005.
Item 4: Submission of Matters to a Vote of Security Holders
During the first quarter, our sole shareholder acted by written consent to approve our Restated Certificate of Incorporation.
Item 1.01. Entry into a Material Definitive Agreement
On May 11,2005 the Board of Directors of BHI Acquisition granted options to purchase shares of BHI Acquisition common stock to Messrs. Harris, Kleinman, and Seminara. Each director received options to purchase 60,566 shares at $2.89 per share. The options have a term of ten years and are automatically exercised upon the occurrence of an initial public offering of equity securities of the Company or of BHI Acquisition.
36
(10) |
Form of Non-Qualified Stock Option Agreement between BHI Acquisition Corp. and certain non-employee directors dated May 11, 2005. | |||
(31) |
Rule 13a-14 Certifications | |||
(a) |
Certificate of the Chief Executive Officer | |||
(b) |
Certificate of the Chief Financial Officer | |||
(32) |
Section 1350 Certifications |
37
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
BORDEN CHEMICAL, INC. | ||
Date: May 16, 2005 |
/s/ William H. Carter | |
William H. Carter | ||
Executive Vice President and | ||
Chief Financial Officer | ||
(Principal Financial Officer) |
38